A Comparison of Smoking Cessation Methods in Normal Smokers and Smokers with Chronic Obstructive Pulmonary Disease by Mueller, Mary Beth
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Open-Access* Master's Theses from the University
of Nebraska-Lincoln Libraries at University of Nebraska-Lincoln
5-1990
A Comparison of Smoking Cessation Methods in




Follow this and additional works at: http://digitalcommons.unl.edu/opentheses
Part of the Health and Physical Education Commons, Medical Education Commons, and the
Public Health Education and Promotion Commons
This Thesis is brought to you for free and open access by the Libraries at University of Nebraska-Lincoln at DigitalCommons@University of Nebraska -
Lincoln. It has been accepted for inclusion in Open-Access* Master's Theses from the University of Nebraska-Lincoln by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.
Mueller, Mary Beth, "A Comparison of Smoking Cessation Methods in Normal Smokers and Smokers with Chronic Obstructive
Pulmonary Disease" (1990). Open-Access* Master's Theses from the University of Nebraska-Lincoln. 12.
http://digitalcommons.unl.edu/opentheses/12
A COMPARISON OF SMOKING CESSATION 
METHODS IN NORMAL SMOKERS AND 
SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
by 
Mary Beth Mueller 
A THESIS 
Presented to the Faculty of 
The Graduate College in the University of Nebraska 
In Partial Fulfillment of Requirements 
for the Degree of Master of Education 
Major: Health, Physical Education and Recreation 
Under the Supervision of Professor Gary L. Martin 
Lincoln, Nebraska 
May 1990 
A COMPARISON OF THREE 
SMOKING CESSATION TREATMENT METHODS 
IN NORMAL SMOKERS AND CHRONIC 
OBSTRUCTIVE PULMONARY DISEASE 
Mary Beth Mueller, M.Ed. 
University of Nebraska, 1990 
Adviser: Gary L. Martin 
Cigarette smoking is the most important health issue of 
our time and the most preventable cause of disease and 
death. Chronic obstructive pulmonary disease (COPD) is a 
frequent consequence of chronic cigarette smoke exposure. 
Patients with COPD who have not stopped smoking earlier in 
the course of their disease are particularly refractory to 
current smoking interventions. Most of the current smoking 
cessation programs are designed for an asymptomatic, 
non-diseased population and report moderate results at best. 
Recent studies suggest the idea of individualizing treatment 
and tailoring smoking cessation therapies to each smoker. 
This study investigated three smoking cessation therapies in 
two groups of smokers in an attempt to define which therapy 
was best for different types of smokers. 
Thirty asymptomatic cigarette smokers and thirty 
smokers with COPD were randomized into one of three smoking 
cessation treatments: Individual, Group, or Self-help 
therapy. The treatment period was for four weeks and was 
guided by the American Cancer Society's FreshStart program. 
Smoking abstinence was verified by exhaled carbon monoxide 
levels. 
Using carbon monoxide, a split-plot analysis of 
variance was performed. Mean carbon monoxide levels were 
significantly lower post-treatment for all subjects. 
Individual and Group therapy were found to be significantly 
different than the Self-help group overall. 
The same split-plot analysis of variance was performed 
for number of cigarettes smoked. Mean number of cigarettes 
smoked were significantly lower post-treatment for all 
subjects and normal smokers were able to reduce their 
cigarettes more than the COPD group. Chi-square and 
discriminant analysis using demographic variables, tobacco 
dependency and self-efficacy failed to predict success. The 
COPD group reported significantly increased anxiety and 
restlessness over the normal smokers group. 
Overall, there were decreases in both carbon monoxide 
and cigarettes smoked. These results justify the program 
expense of intensive cessation treatments such as Individual 
and Group over Self-help therapy. Normal smokers were able 
to significantly reduce the number of cigarettes smoked over 
the COPD group but otherwise grouping effects were not found 
to be significant. Further research characterizing smokers 
and individualizing smoking cessation therapy is needed. 
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overview of the Health Problem 
There have been dramatic changes in the health status 
of Americans over the past century. At the beginning of the 
century, the leading causes of death were infections such as 
pneumonia, diphtheria, influenza, tuberculosis and 
gastrointestinal infections (Nebraska Health Education/Risk 
Reduction Program, 1986). Today, the leading causes of 
death are in part, self-inflicted: coronary heart disease, 
cancer, stroke and chronic obstructive lung disease. 
Throughout life, we make many decisions that affect our 
health. The sum total of these decisions comprise our 
lifestyle. The cumulative impact of lifestyle decisions has 
a greater effect on the length and quality of life than all 
the efforts of medical care combined (U.S. Department of 
Health Education and Welfare, Healthy People, 1979). 
It has been a quarter of a century since the Surgeon 
General dispelled all doubt that smoking is our greatest 
preventable cause of disease and premature death (U.S. 
Public Health Service, 1964). In 1986, a second most 
important surgeon General's report appeared. It included 
scientific evidence to condemn cigarette smoke as one of our 
most important environmental hazards. The report showed 
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that tobacco was a serious threat not only to the lives of 
smokers, but to their nonsmoking spouses, children and 
co-workers (U.S. Department of Health and Human Services, 
1986). 
Indeed, cigarette smoking has been proclaimed to be the 
most important public health issue of our time (U.S. 
Department of Health and Human Services, Smoking and Health, 
1987). The Royal College of Physicians in London recently 
concluded that cigarette smoking constitutes the largest 
single remaining preventable cause of death and disease. 
Despite widespread public health efforts to provide 
education and encouragement to smokers to stop, many people 
have great difficulty quitting even though they are well 
motivated (Hjalmarson, 1984). 
Just about everyone agrees that the use of tobacco is 
damaging to one's health. Nonetheless, while the percent of 
smokers in the United States has declined from 42 percent in 
1965 (U.S. Department of Health and Human Services, 1982) to 
just under 33 percent in 1983 (National Center for Health 
statistics, 1984) the total number of smokers has remained 
almost constant. The overall prevalence of smoking among 
males declined dramatically after the first U.S. Surgeon 
General's report on smoking and health was issued in 1964 
(U.S. Department of Health and Human Services, 1988). This 
decline has continued among males, but the speed of the 
decline has diminished. In some categories, such as for 
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women between 20 and 34 years, the percent of smokers 
increased from 1980 to 1983 (National Center for Health 
Statistics, 1984). Lung cancer now exceeds breast cancer in 
American females (U.S. Department of Health and Human 
Services (Smoking in the United States, 1986). 
Health Consequences of Smoking 
With the exception of the tobacco industry, few would 
dispute the connection between cigarette smoking and 
preventable morbidity and premature mortality (U.S. 
Department of Health, Education and Welfare, Smoking and 
Health, 1979). It has been estimated that there are more 
than 50,000 studies linking cigarette smoking to increased 
morbidity and mortality from cardiovascular diseases, 
various forms of cancer and chronic obstructive lung 
diseases (U.S. Department of Health and Human Services, The 
Health Consequences of Smoking, 1985). For example, there 
is epidemiologic evidence linking smoking with coronary 
heart disease, lung cancer, emphysema, laryngeal and 
esophageal cancers, cancer of the bladder, and several 
gastrointestinal diseases (e.g., peptic and duodenal ulcers) 
(Fielding, 1985). 
Each year, 340,000 persons die prematurely from 
smoking-related illnesses. The Surgeon General has stated 
that unless smoking habits change, 1 in every 10 people 
living today could die prematurely of heart disease alone 
(U.S. Department of Health and Human Services, 1983). In 
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addition to smoking's contribution to heart disease, it is 
estimated that 30 percent of all cancers are caused by 
smoking and that 85 percent of all lung cancers are due to 
cigarette smoking (U.S. Department of Health, Education and 
Welfare, 1982). 
Chronic obstructive pulmonary disease (COPD) is a 
frequent consequence of chronic cigarette smoke exposure. 
COPD refers specifically to obstructive lung disease such as 
chronic bronchitis and emphysema. The American Thoracic 
society's definition of chronic bronchitis is the presence 
of a chronic, productive cough for at least three months of 
the year for the last two years {U.S. Department of Health 
and Human Services, smoking and Health, 1987). Examination 
of COPD mortality rates for smokers and non-smokers suggest 
that 85-90 % of deaths due to obstructive lung disease can 
be attributed to cigarette smoking (U.S. Department of 
Health and Human Services, 1984). In general, cigarette 
smokers have a 70% greater death rate from all causes than 
non-smokers (U.S. Department of Health and Human Services, 
Smoking and Health, 1987). 
Economic Consequences of Smoking 
The health consequences and medical costs associated 
with cigarette smoking have been established undeniably. 
Not only are cigarette smokers at markedly increased risk of 
morbidity and mortality, chronic obstructive pulmonary 
disease accounts for a sizeable amount of disability in the 
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labor force (U.S. Department of Health and Human Services, 
1985). The costs to society of supporting wage-earners 
disabled from smoking-related disease and their dependents 
can be exorbitant. Premature deaths secondary to lung 
disease also has a costly impact on society. Forty two 
billion dollars is spent annually for medical care and lost 
productivity due to smoking. In addition, each individual 
who is a non-smoker for one year save about $837.23 due to 
the cost of cigarettes (U.S. Department of Health and Human 
Services, A Decision Makers Guide, 1985). 
As a society, it seems less expensive to prevent 
smoking-related disease than carry the economic burden for 
those who become disabled and economically unproductive. If 
this particular health problem were controlled, medical 
costs could be reduced. While numerous techniques have been 
developed to improve the quality of life for patients with 
lung disease, there has been growing realization that while 
smoking is a prevalent and costly public problem, it is also 
preventable. 
Declining Social Acceptability of Smoking 
A great social movement has taken root to rid America 
of its tobacco use. The social acceptability of cigarette 
smoking has declined in the last two decades. Efforts still 
continue to promote a strongly developing social climate 
against smoking. Smokers who smoke in the presence of their 
nonsmoking friends increasingly feel as though they are a 
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"dragon." Much attention has been given to the airline 
industry regarding the recent smoking ban for passengers and 
support personnel on all commercial flights. Furthermore, 
smoke-filled environments are being established in an 
increasing number of public buildings. By 1979, almost half 
of all U.S. businesses had a policy restricting or 
prohibiting smoking (Windsor & Bartlett, 1984). 
Smoking and the Health-Illness Continuum 
Countless public education programs have attempted to 
promote effective self-regulation of illness threats, such 
as smoking, however, people continue to engage in behaviors 
which are dangerous to their health (Leventhal, Safer, 
Panagis, 1983). Because so many of the illnesses today are 
in part self-inflicted, the prevention and treatment of 
these illnesses involve the modification and control of 
behavior. 
It is important to consider health as separate from 
illness. Many people define illness as ill health and 
health as lack of illness. Greenberg (1985) suggests that 
there is a health-illness continuum and that there are many 
behavioral dimensions of health and illness. Kasl (1974) 
suggests the major reason for distinguishing "health" and 
"illness" is because different sets of determinants are 
needed to understand them. Health behavior takes place in 
the absence of symptoms and forms the direction of primary 
health education programs. Illness behavior on the other 
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hand, takes place in the presence of symptoms and may 
sometimes be compelling enough to provide all the motivation 
a person may need. With regard to smoking, some smokers are 
healthy and have no symptomatic complaints (normal smokers), 
while other smokers complain of a chronic, productive cough 
(COPD). 
The Role of Self-efficacy 
While it seems that we have little control over health 
and illness, much of the recent smoking cessation literature 
(Baer, Holt & Lichtenstein, 1986; Best & Hakstian, 1978; 
Condiotte & Lichtenstein, 1981; Yates & Thain, 1985) 
discusses the role of self-efficacy in a person's ability to 
control their own behavior. Albert Bandura (1969, 1977a, 
1977b, 1982, 1986) describes perceived self-efficacy as an 
individual's perception of the likelihood that they would be 
able to perform a specific behavior in a given situation. 
Self-efficacy affects what activities a person chooses to 
pursue, how much effort will be mobilized in a given 
endeavor, how long one will persevere in the face of 
difficulty, and the amount of stress that is experienced. 
Clinical experience suggests that self-efficacy plays a role 
in the motivation to enroll and persist in a behavior change 
program. 
The Role of Tobacco Dependency 
Tobacco dependency seems to surface as an important 
predictor of outcome in smoking cessation programs 
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(Fagerstrom, 1978). Twenty-seven percent of all smokers are 
considered heavy smokers in that they smoke 25 or more 
cigarettes a day (National Center for Health Statistics, 
1985). Heavy smokers are three to four times more likely to 
die of cancer than non-smokers (U.S. Department of Health, 
Education and Welfare, 1979). Heavy smokers who have a 
greater dependence on nicotine offer a major challenge to 
smoking cessation. 
current Trends Toward Smoking Cessation 
Since cigarette smoking has been recognized by the 
Surgeon General as the most preventable cause of disease in 
the United States, many Americans have quit smoking and many 
more smokers are eager to quit. In 1966, just 26 percent of 
smokers said they were trying to quit; 16 years later, the 
figure had risen to 37 percent (U.S. Department of Health 
and Human Services, Smoking and Health, 1983). The 
proportion of individuals who have never smoked also has 
risen, although more slowly, from almost 28 percent in 1960 
to almost 32 percent in 1980 (U.S. Department of Health and 
Human Services, Smoking and Health, 1983). Yet, there are 
many smokers whose common denominator is their inability to 
stop smoking on their own. Cigarette smoking is an 
extremely complex and highly refractory behavior. In spite 
of the enormous scientific efforts during recent decades, 
the clinician's armamentum in smoking cessation has not 
improved all that much. 
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Despite knowledge of the health consequences of 
cigarette smoking, approximately one third of adults in the 
United States continue to smoke (Remington, Forman, Gentry, 
Marks, Trowbridge, 1985). Smoking cessation efforts are 
impeded because many of the advantages of continuing smoking 
are immediate, whereas the disadvantages of smoking are 
delayed (Klesges et al. 1988). 
Research programs designed to reduce cigarette smoking 
have increased dramatically in the last two decades. Most 
programs continue to be designed for the asymptomatic 
non-diseased smoker. The most recent reviews suggest more 
promising results, particularly from multi-component 
behaviorally oriented treatment programs (Glasgow & 
Bernstein, 1981; Pechacek, 1979). 
Only a small number of smoking cessation studies have 
been reported in which smokers with chronic disease are the 
target population (Sirota, Currlan, Habif, 1985). Although 
it has been reported that many smokers with cardiac and 
pulmonary disease quit smoking when given medical advice 
(Pederson & Baskerville, 1983), those that do not represent 
a particularly difficult group to treat (Hall, Bachman, 
Henderson, Barstow & Jones, 1983). Quitting smoking for 
this segment of the population is crucial. A sizeable 
proportion of patients with diagnosed lung disease continue 
to smoke despite warnings from physicians. Long-term 
results of treatments for chronic cigarette smoking have 
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generally been discouraging (Hunt & Bespalec, 1974; 
Lichtenstein & Danaher, 1976). Patients with underlying 
chronic obstructive pulmonary disease, who have not stopped 
smoking earlier in the course of their disease, may be 
particularly refractory to current smoking interventions. 
Disappointing smoking cessation results for these 
recalcitrant smokers demonstrates the need for the 
investigation of different smoking cessation approaches. It 
is clear that smokers exhibit a high degree of individual 
difference. Perhaps smokers need to be further 
characterized and smoking cessation therapy conditions 
individually tailored. 
Need For Individualizing Treatment 
Cigarette smoking is a complicated behavior and highly 
individualized. Each individual who smokes does so for 
their own reasons and supports their behavior with 
underlying personality characteristics. Little research has 
been done on analysis of those personality characteristics 
predictive of treatment success or failure. Decisions 
regarding which components to use in treatment programs for 
individual subjects are still based on clinical intuition 
rather than empirical findings (Pomerleau, Adkins, 
Pertschuk, 1978). Pomerleau et al. (1978) also suggested 
that smoking cessation results might be enhanced by 
providing components which take into account individual 
subject characteristics. Their objective was to demonstrate 
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the role of personality characteristics in determining 
outcome in smoking cessation and to demonstrate 
empirically-based suggestions for individualizing 
treatment. 
With rising medical costs, we need to develop a clear 
understanding of the "person-intervention-fit" (Pechacek, 
1979). An individualized smoking cessation program can help 
make intervention more cost-effective and can help to decide 
whether certain individuals need more intensive 
interventions while others would do just as well with 
minimal contact. As with any medication regimen, health 
care providers should tailor smoking control strategies to 
the individual. 
Purpose of the Study 
This research was designed to investigate whether there 
would be a difference in mean exhaled carbon monoxide levels 
and mean number of cigarettes smoked for two randomized 
groups of smokers. smoking cessation therapy was 
manipulated in smokers with a chronic, productive cough 
(COPD) and those who were asymptomatic (normal). Individual 
therapy was compared with group therapy and these were 
compared to self-help therapy. The main purpose of this 
study was an attempt to define the smoking cessation therapy 
that worked best for each of these two groups. With the 
information gained from this research, it was hoped that 
educating different types of smokers (those with and without 
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lung disease) about the smoking cessation therapy that may 
work best for them would lead to the most optimal voluntary 
behavior changes. Other purposes included describing the 
relationship between demographic information and smoking 
cessation outcome. 
This smoking cessation program provided the opportunity 
to look at 1) process (a better definition of smoking 
cessation therapies in different types of smokers), 2) 
impact (smoking cessation) and 3) outcome (prevent further 
progression of COPD and increase quality of life). It also 
focused on a more tailored smoking cessation program for 
smokers with individual variances. It was hoped that this 
study may be used to show that an individually-tailored 
smoking cessation paradigm can be effective in any 
clinic-based practice setting for different types of 
smokers. Practical implications to support this study 
include the ability to predict successful smoking cessation 
attempts in patients with lung disease based on their 
self-efficacy and tobacco dependency. Equally important, an 
assessment of the most effective behavior modification 
approach for each of these two groups of smokers was 
investigated. 
Assumption of the Study 
The assumption for this study was that smoking 
cessation effectiveness depends on further characterization 
of smokers. For example, it was assumed that smokers with 
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COPD, higher tobacco dependency and lower self-efficacy 
scores would find it most difficult to quit regardless of 
the treatment method assigned. It was not the assumption of 
the principal investigator that all subjects would be able 
to quit smoking. In fact, this research may have had an 
effect without any successful quitters. For example, if 
this study showed only a mean decrease in carbon monoxide 
levels or number of cigarettes smoked, it would still be 
considered valuable in a practical sense. 
Hypotheses of the study 
The hypotheses for the present study were derived from 
assumptions of behavioral smoking treatment, literature on 
the strategies associated with treatment success and 
evidence implicating tobacco dependency and self-efficacy as 
major determinants. In accord with these sources, three 
smoking cessation treatment methods were compared in two 
groups of smokers. This study was designed to investigate 
the following null hypotheses: 
Hypothesis 1: 
There will be no significant difference (R<.05) in 
pre/post mean exhaled carbon monoxide levels between 
treatment groups when therapy (individual vs group vs 
self-help) is manipulated in smokers with and without COPD. 
Hypothesis 2: 
There will be no significant difference (R< .05) in 
pre/post mean number of daily cigarettes smoked between 
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treatment groups when therapy (individual vs group vs 
self-help) is manipulated in smokers with and without COPD. 
Hypothesis 3: 
There will be no difference in the frequency of success 
between groups when therapy is manipulated. 
Hypothesis 4: 
There will be no relationship between demographic 
variables and smoking cessation outcome between groups. 
Hypothesis 5: 
There will be no relationship between tobacco 
dependency and smoking cessation outcome between groups. 
Hypothesis 6: 
There will be no relationship between self-efficacy and 
smoking cessation outcome between groups. 
Hypothesis 7: 
There will be no relationship between smoking cessation 
withdrawal symptoms and outcome between groups. 
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CHAPI'ER TWO 
REVIEW OF THE LITERATURE 
Smoking and Chronic Obstructive Pulmonary Disease 
Cigarette smoking is dangerous to health and has been 
well established as a major cause of disease. Despite this, 
smoking continues to be a prevalent health-defeating 
behavior, even among persons who have an illness related to 
smoking (Mausner, 1970). For many of these individuals, 
continued smoking is a "self-inflicted suicide" and 
inevitably contributes to the progressive deterioration of 
their condition. 
Chronic obstructive pulmonary disease (COPD) is a 
frequent consequence of chronic cigarette smoke exposure. 
The American Thoracic Society's definition of COPD is the 
presence of a chronic, productive cough for at least three 
months of the year for the last two years (U.S. Department 
of Health and Human Services, Smoking and Health, 1987) Two 
disorders, emphysema and chronic bronchitis comprise the 
majority of cases diagnosed as COPD. Chronic bronchitis and 
emphysema are progressive, insidious in onset and may 
ultimately result in death by respiratory and/or cardiac 
failure. 
Cigarette smoking has been implicated as the most 
common cause of chronic bronchitis, emphysema and lung 
cancer (U.S. Department of Health and Human Services, 
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Smoking and Health, 1987). In the airway, cigarette smoke 
causes an increase in mucous gland size and number. These 
changes result in increased mucous production leading to a 
chronic productive cough, the main feature of COPD. Smokers 
of both sexes have a higher prevalence of cough and phlegm 
production than nonsmokers (Sachs, Benowitz, Silver, 1987). 
This prevalence increases with the number of cigarettes 
smoked per day. These inflammatory changes may lead to 
airflow obstruction which is often reversible with the 
cessation of smoking. If the smoker continues to smoke, 
however, irreversible changes leading to the development of 
emphysema will occur. In addition, cigarette smoking 
paralyzes the tiny hair-like structures which clean and 
protect the lung. Therefore, cigarette smokers are more 
vulnerable to viral and bacterial pathogens and are 
subsequently at greater risk for developing infection. 
Because the development of a productive cough is so 
insidious, this pathologic symptom is often not viewed as a 
generalized danger signal. 
In a study by Chetwynd and Rayner (1986), smokers were 
found more likely to report frequent occurrence of all 
symptoms. Smokers averaged 3.31/year illness episodes 
compared with 2.54/year among nonsmokers. Smokers made 
significantly greater use of general practitioners and 
hospitals, paid more visits to specialists, outpatient 
clinics and chiropractors, and had more emergency admissions 
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than nonsmokers. Heavy smokers reported more illnesses and 
greater use of health care facilities than light smokers. 
overall, smokers averaged 0.81 additional visits annually to 
their general practitioner than nonsmokers, an increase of 
16.5 percent. 
Preventive elements are among the more important 
aspects of health care management of patients with COPD. Of 
the factors which have been addressed in reports of health 
promotion and education for patients with a respiratory 
problem, two have been identified as having a considerable 
potential for increased health benefit: appropriate use of 
prescribed medications and smoking cessation (Windsor et al. 
1980). According to the 1974 National Ambulatory Medical 
Care Survey (NAMCS): 1) high levels of smoking behavior 
were reported by those with COPD and 2) 63% of the 
respondents with chronic bronchitis and/or emphysema 
indicated taking at least one medication for their 
respiratory problems. 
Cessation of smoking leads to a decreased risk of 
mortality from COPD compared with that of continuing 
smokers. The risk of death for the ex-smoker is directly 
proportional to the overall lifetime exposure of cigarette 
smoke and to the total number of years since one quit 
smoking. However, the risk of COPD mortality among former 
smokers does not decline to equal that of the never smoker 
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even after 20 years cessation (U.S. Health and Human 
Services, 1984). 
Hall, Sachs, Hall and Benowitz (1983), studied men and 
women who had cardiovascular or pulmonary disease in a 
smoking cessation program that incorporated some behavioral 
techniques. They reported low abstinence rates, which 
averaged about 16% at six-month follow-up. 
It has been reported that many smokers with pulmonary 
and cardiac disease quit smoking (Pederson & Baskerville, 
1983). In fact, survivors of a myocardial infarction have 
smoking cessation rates that average 50 percent (Sirota et 
al. 1985). Those smokers with pulmonary and cardiac disease 
that do not quit smoking represent a particularly difficult 
group to treat (Hall et al. 1983). 
Dudley, Aickin, and Martin, (1977) and Daughton, Fix, 
Kass, and Patil (1980) found remarkably similar smoking 
cessation rates among two independent groups of COPD 
patients. They both found that roughly two of every three 
COPD patients become ex-smokers, and it appears that most of 
the quitting takes place soon after receiving the first 
pulmonary diagnosis. Less than half of the remaining 
patients ever succeed in breaking the habit. This leaves 
about one COPD patient in five unable to ever quit. 
Daughton et al. (1980), reported that COPD patients compared 
to non-disease smokers, good risks to break the habit. 
Having COPD is an overwhelming factor influencing the 
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ability to quit. Their study suggests that all COPD 
patients will stop smoking would be accurate in two out of 
three cases. 
Behavioral specialists have targeted patients with COPD 
in pulmonary rehabilitation programs. Pulmonary 
rehabilitation experts readily admit that they can provide 
only supportive treatment for the chronically deteriorating 
lung conditions. Immunizations, aggressive initiation of 
antibiotics for infection, and strict adherence to their 
medicine regimen is best management that can be offered • 
. Often, the lungs are the only limiting system for the 
activities of daily work and recreation (Fix, Daughton, 
Kass, 1981). 
Prigatano, Wright and Levin, (1984), showed restriction 
in quality-of-life function and daily life activities in 
patients with COPD. In his study, the degree of physical 
limitation was minimal, but the degree of psychosocial 
limitation was more marked. Fix et al. (1981) suggests that 
certain psychological traits lead some people into 
lifestyles that predispose them to smoke and subsequently 
develop chronic lung disease. 
Windsor et al. (1980) indicates that a significant 
proportion of patients with COPD are receptive to smoking 
behavior change and with education and support, will alter 
their existing behavior of smoking. Furthermore, he implies 
that prevention by modification of smoking behavior clearly 
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offers more hope than the possibility of any new treatment 
for respiratory disease. Unfortunately, little can be done 
to directly modify pre-treatment variables such as rate and 
years of smoking for those interested in quitting. Perhaps, 
participants for them whom a less favorable prognosis is 
predicted can be monitored throughout treatment and be given 
more intensive therapy. 
The Utility of Pulmonary Function Testing 
Current research suggests that the presence of a 
chronic, productive cough, with additional abnormalities in 
pulmonary function testing may identify a population whose 
lung function deteriorates at a more rapid rate than normal 
and who are at increased risk of death. Fix et al. (1981) 
suggested that smokers show reduced lung functions at all 
ages compared to nonsmokers. 
Petty, Pierson, Dick, Hudson and Walker (1976), 
performed a follow-up of a prevalence study of respiratory 
symptoms and chronic airway obstruction after a 6 to 7-year 
interval. Knowledge of the presence of chronic bronchitis 
after the original study had no effect on subject's smoking 
habits, although chronic bronchitis was significantly less 
prevalent at follow-up among those who did stop smoking. 
They also showed that smokers with a forced expiratory 
volume in one second/forced vital capacity (FEVl/FVC) ratio 
in 1967 < 60% showed approximately a three-fold larger 
mortality rate than nonsmokers. It was clear that the 
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presence or absence of chronic obstructive lung disease in 
1967 had no direct bearing on whether the subjects had 
stopped smoking by 1974. However, classification of 
abnormal on the basis of pulmonary function testing may have 
had an influence on smoking cessation. Therefore, while 
little attention was paid to the importance of the actual 
diagnosis of COPD or its symptoms, the classification of 
"abnormal" based on spirometric testing appeared to be a 
motivating factor. 
After approximately age 25, measures of ventilatory 
function progressively decline. The rate of decline in 
measures of expiratory airflow with increasing age is 
steeper for smokers than nonsmokers. It is also steeper for 
heavy smokers than for light smokers. The mean annual rate 
of decline in forced expiratory volume in 1 second (FEVl) 
was 47 ml in healthy nonsmokers, 60 ml in moderate smokers 
and 73 ml in heavy smokers. (Olofssen, Bake & Svardsuda, 
1986). 
Researchers have shown that improvements in pulmonary 
function can occur subsequent to smoking cessation (Bosse, 
Sparrow, Rose & Weiss, 1981; Nemery, Moqvero, Brasseur & 
Stanescu, 1982). Smoking cessation can slow the rate of 
pulmonary function decline in patients with mild to moderate 
COPD. If cigarette abstinence occurs early enough, COPD 
patients with mild dysfunction may delay or perhaps 
eliminate their predicted encounter with severe pulmonary 
impairment. After the cessation of smoking, the rate of 
lung function decline with increasing age appears to slow to 
approximately that seen in nonsmokers of the same age. 
Since pulmonary function testing is simple and can be 
performed by non-physicians, it seems reasonable to 
encourage early identification of patients at risk. This 
simple procedure may be the first step in the institution of 
preventive and therapeutic measures that might be effective 
in relieving symptoms and stopping the progress of the 
disease. 
Illness Behavior 
Illness is often still viewed as a matter of random 
chance, not to be averted but to be tolerated and accepted 
(U.S. Department of Health and Human Services, 1979). 
People behave differently as a result of illness because it 
is often viewed by society as a weakness. The public is 
confronted with media showing us glowing and youthful 
beautiful women with peaches and cream complexions, perfect 
white teeth, and shiny, silky hair. Likewise, men are 
depicted as handsome and virile with muscular tan bodies, 
perfect teeth, and well-groomed hair. Wellness and youth 
are both highly valued. Furthermore, our economy is based 
on the "healthy employee." Even though companies or 
businesses make provisions for sick leave, individuals who 
use this provision may run the risk of not being recommended 
for promotion and/or salary increase. Individuals often 
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feel compelled to come to work regardless of how sick they 
feel. Rather than face the reality of illness with its 
feelings of guilt and lack of rewards, the individual may 
avoid or deny the fact that he or she is ill (Mechanic, 
197 8) • 
The thrust of our culture is directed toward physical 
perfection and health. It's not surprising, then, that 
people are taken off guard when the threat of illness 
becomes a reality. Suddenly there exists a tremendous 
threat to the individual's self-system and subsequent 
alteration of self. Because of this threat, the individual 
has to make adaptive changes depending upon the type of 
illness, severity of the illness and threat to the person's 
self-concept. Adaptation to chronic disease is a lengthy 
and ongoing process. The illness may force the individual 
to act differently than in complete health. 
The social perspective of illness behavior takes into 
account the norms involving sickness and response to 
sickness. The social perspective also determines the 
conditions under which a person can claim illness and be 
released from usual social obligations. If we regard sick 
people as having to be "looked after" rather than helped to 
health, we may unwittingly reinforce their passive 
tendencies and encourage them to leave it all to us. 
The term "illness" can be used in two ways. It can 
refer to the medical disease model or to any condition that 
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causes an individual to concern himself with his symptoms 
and seek help. the term "illness behavior" refers to the 
latter. The study of the patient's perspective is a useful 
aspect of the analysis of health and disease. Because 
illness behavior affects the utilization of medical care, 
the selection of patients who seek help from general 
practitioners, clinics, or hospitals is usually biased. 
(Mechanic, 1978). 
Mausner (1970) found that the fact of being ill was a 
major consideration in patients' decisions to stop smoking. 
Cessation, however, was only limited to persons with severe 
obstructive symptoms. Probably the presence of symptoms, 
the knowledge of abnormal radiographic findings, the 
realization of the poor prognosis if their disease continued 
its course, and the warnings from health care professionals 
all contributed in varying proportions to the decision to 
stop smoking. 
For a COPD patient, knowing their illness is 
irreversible may lead to feeling of hopelessness and fear of 
losing control. Independence and pride may be lost as 
patients are forced to retire, change their recreational 
activities and rely on others for assistance as their 
disease progresses. Feelings of inadequacy may result when 
social roles change. A major part of self image is related 
to body image perceptions, attitudes and feelings that we 
have toward our bodies (Dudley, Zitzman, Rugg, 1985). 
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Health Belief Model and Smoking Cessation in The COPD 
Patient 
The Health Belief Model (Rosenstock, Strecher, Becker, 
1988) contends that behavior change depends on the 
interaction of three psychological factors: how seriously 
patients perceive a disease; how much benefit the patient 
expects from the treatment; and how difficult, bothersome or 
painful the patient expects therapy to be. Because smoking 
is often perceived as a pleasure, the immediate discomfort 
of abstinence is pitted against the less immediate risk of 
serious disease (Fix et al. 1981). Although medical 
opinions of the seriousness of disease have little 
association with patient compliance rates, patients' views 
of the severity and their perceived personal susceptibility 
to a disease both affect compliance. Higher compliance 
rates are found among patients who perceive their medical 
risks as great. During asymptomatic periods, patients may 
perceive their disease as less severe and predictably, when 
patients are asymptomatic, medication compliance drops. 
Consider this example: A person may evaluate their 
cigarette smoking because it is a threat to lung cancer. 
They may deny their susceptibility, agree with the 
seriousness of the disease but realize the perceived 
treatment is poor and if they stop smoking, they loose the 
benefits of being a smoker. For these reasons, they may 
continue to smoke. 
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In reviewing the importance of social definitions in 
response to illness, it is essential to remember the 
character of the symptoms themselves. Much of the behavior 
of sick persons is direct product of the specific symptoms 
they experience: their intensity, the quality of discomfort 
they cause and their persistence. (Mechanic, 1978). Whether 
a person recognizes a productive cough as a symptom of an 
illness depends on how recognizable and the degree of 
disturbance. Because the natural history of the disease is 
not widely disseminated by medical professionals, smokers 
may not realize their susceptibility--that a productive 
cough is the initial symptom of chronic lung disease. They 
may also not be aware of the seriousness of this seemingly 
benign cough and its potential to lead to irreversible lung 
damage. Health care professionals need to place more 
emphasis on explaining the clinical course of lung disease. 
More effort should concentrate on having smokers appreciate 
that their minor chronic symptoms are caused by smoking and 
that nonsmokers experience fewer complaints. 
Rosenstock's (1988) Health Belief Model states that if 
smokers do not understand the course of the disease process, 
they are likely to perceive that they will not be 
susceptible. Furthermore, they will fail to understand the 
seriousness of their seemingly benign chronic cough and its 
ultimate airflow obstruction. Due to their physiologic 
addiction to nicotine, they will view quitting smoking as a 
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barrier with little benefit. In a study by Hansen and 
Malotte (1986), smokers were more likely than nonsmokers to 
deny their susceptibility both for others and for themselves 
as hypothetical lifelong smokers when asked to estimate the 
probabilities of consequences from cigarette smoking. 
In illness behavior, smokers who have COPD are already 
in the medical care circle. Perceived susceptibility is not 
an issue because the patient already has the disease. 
Perceived seriousness and barriers to quitting may take on 
greater significance (Rosenstock et al. 1988). If we look 
at the issue of smoking cessation from the viewpoint of the 
person who has COPD, one may see healthy smokers who need to 
quit but then continue to be healthy. On the other hand, 
one sees sick smokers who also need to quit but continue to 
stay sick. The instrumental value of quitting may not 
provide enough incentive or motivation to quit smoking. 
Tobacco Dependency 
Cigarette smoking continues to be an extremely 
tenacious addiction. Evidence now clearly indicates that 
nicotine, similar to alcohol and opiates, is a potent 
dependence-producing drug (Henningfield & Jasinski, 1983; 
Jaffe & Kanzler, 1979). Most smokers say they want to quit 
but only one in three stops permanently before age 66 
(Russell & Jarvis, 1985). 
Conclusions of the 1988 Surgeon's General Report are 1) 
cigarettes and other forms of tobacco are addicting; 
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2) nicotine is the drug in tobacco that causes addiction, 
and 3) the pharmacologic and behavioral processes that 
determine tobacco addiction are similar to those that 
determine addiction to drugs such as heroin or cocaine (U.S. 
Department of Health and Human Services, 1988). 
The level of tobacco dependence will vary across 
smokers. Previous studies have shown that the higher the 
tobacco dependency, the more recalcitrant the smoker is to 
smoking cessation attempts (U.S. Department of Health and 
Human Services, Smoking and Health, 1987). 
Glasgow, Klesges, Klesges, Somes, (1988) and Klesges et 
al. (1988) found in two separate studies that subjects with 
heavier, more recalcitrant smoking habits are the most 
likely to join a stop-smoking program but the least likely 
quit. 
Recidivism is a major obstacle to successful cessation 
efforts. studies show that quitting is often a result of 
persistence. In one study, only 25% of the participants 
quit on the first try, but by the fourth attempt, 73.4% of 
the total participants had kicked the habit (U.S. Department 
of Health Education and Welfare, 1979). Patients with COPD 
have higher rates of quitting the smoking habit than do 
smokers generally, but many continue to smoke to the end. 
Sachs et al. (1987) reported that a typical patient referred 
to a lung specialist has tried 8.2 times to seriously stop 
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smoking in the past using a mean of 2.3 totally different 
techniques. 
The ability to stop smoking appears to be related to 
the habit itself. Over 90% of all smokers begin smoking 
before age 20. An early age of initiation is inversely 
related to current smoking status, that is, the earlier one 
begins smoking as a teenager, the less likely that 
individual will be successful in giving up smoking as an 
adult. An earlier age of smoking initiation is strongly 
correlated with becoming a heavy smoker, thus further 
increasing the risk of premature death and disability (U.S. 
Department of Health and Human Services, Smoking and Health, 
1987) • 
Daughton et al. (1980) showed that only pack-years 
emerged as a significant discriminant between patients at 
follow-up who had quit and those who continued to smoke 
(Q<.05). The only relapses occurred in heavy smokers with 
greater than a 55 pack-year history. Nelson (1977) showed 
similar findings that in a healthy population, pack-years is 
one of the best predictors of smoking cessation, with the 
heaviest smokers being least likely to quit. A 
well-established pattern of smoking appears difficult to 
change regardless of whether a heavy smoker is healthy or 
has COPD. 
Heavy smokers, compared to lighter smokers are at 
increased risk of death by heart disease, lung cancer and 
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chronic obstructive pulmonary disease. Previous studies 
have shown that treatment of the primary disorder, tobacco 
dependence, produces better long-term cure rates than we can 
presently achieve for major secondary disorders caused by 
tobacco dependence: chronic obstructive pulmonary disease 
or lung cancer. 
Smoking Cessation 
On a general level, the hazards of smoking are 
well-known. It appears that knowledge about the health 
effects of smoking is not by itself a deterrent to 
cessation. Smoking is an overlearned behavior. Many 
smokers needed to learn how to smoke when they first started 
smoking. Experience from ex-smokers appear to support that 
smokers can slowly and methodically unlearn smoking behavior 
as they gradually weaken the series of strong associations 
formerly linked to smoking. Thus, behavioral modification 
is essential in any smoking cessation program aiming to 
achieve long-term success. 
Numerous methods and techniques for prompting smoking 
cessation have been advocated and developed. However, 
long-term results are only moderate. One-year success rates 
vary less than 10% based on doctors' advice (Russell et al. 
1979), to about 20% in smoking cessation clinics (Bernstein 
& Glasgow, 1979; Orleanse, 1980; Hughes, 1984), to a few 
reports of more than 30% when pharmacological adjuncts are 
utilized. The more promising approaches utilize a 
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combination of intervention techniques, and more 
importantly, take into account physiological dependence and 
the need for maintenance strategies. 
In population surveys, it appears that the American 
public wants to quit. Of a sample interviewed, half 
indicated a desire to quit (American Institute of Public 
Opinion, 1974). A large number of people have attempted to 
quit in the last three decades. The percent of smokers in 
the United states declined from 42 percent in 1965 (U.S. 
Department of Health and Human Services, 1982) to just under 
33 percent in 1983 (National Center for Health Statistics, 
1984). 
The immediate consequences of quitting smoking are very 
negative. A highly overlearned behavior is no longer 
available for reinforcement, and nicotine withdrawal 
symptoms may occur (e.g. increased coughing, irritability, 
craving, restlessness, weight gain). While long-term 
advantages of smoking cessation are dramatic, they cannot be 
guaranteed (Klesges et al. 1988). 
In an attempt to determine predictors of success in a 
multi-component behavioral treatment program for smoking 
cessation, Pomerleau et al. (1978) found that those who had 
abstained from smoking after eight weeks of treatment had 
smoked at lower rates and for shorter periods of time, were 
less overweight, experienced fewer withdrawal symptoms, and 
who were more compliant with the treatment program. 
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Kasl (1974) showed that among the sociodemographic 
variables, males and older married persons have better 
success. Wife's disapproval of smoking increased the chance 
of success, but not the other way around; in fact, 
disapproval from friends and relatives increased the female 
smokers' chances of failure (Coppotelli & Orleans, 1985). 
The mechanisms underlying gender differences in smoking 
cessation maintenances have not been systematically 
explored, but women react more adversely to unwanted changes 
accompanying quitting, especially temporary moodiness and 
weight gain, because they find such changes to be greater 
social liabilities (U.S. Department of Health and Human 
Services, Healthy People, 1979). 
Dudley et al. (1977) confirmed that patients with high 
psychosocial assets have several behaviors to substitute for 
that of smoking. These patients, he suggested, are 
psychologically stable and their psychologic comfort is not 
seriously threatened if they need to stop smoking. Daughton 
et al. (1980) also reported that psychosocial assets and 
pack-years smoking history significantly differentiated 
smokers from ex-smokers at follow-up. 
Kasl (1974) concludes that persons who expect to be 
successful, are confident of their ability to quit, are 
accepting of treatment, and attend regularly, are more 
likely to quit smoking. Those who drop out of treatment at 
a point where they have already quit are more likely to be 
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successful at follow-up than those who stay in treatment; 
but dropouts who don't quit are almost certain to remain 
failures. 
Self-efficacy 
Because smoking continues to be characterized by high 
rates of recidivism, investigators have turned to cognitive 
theories such as Bandura's (1977) concept of self-efficacy. 
Self-efficacy is an element of Bandura's (1986) Social 
Cognitive Theory. Bandura holds that behavior is 
determined, in part, by cognitive factors which mediate 
eventual behavior change through expectancies and 
incentives. Self-efficacy is the expectancy about ones own 
competence to perform the behavior needed to influence 
outcomes. 
Bandura (1977) outlines the role of self-efficacy in 
the paradigm of a person engaging in a behavior that will 
have a subsequent outcome: 
PERSON --------------> BEHAVIOR ------------> OUTCOME 
r Efficacy r Outcome 
Expectations Expectations 
In order for a man or a woman (PERSON) to quit smoking 
(BEHAVIOR) for health reasons (OUTCOME), he or she must 
believe both that cessation will benefit their health 
(OUTCOME EXPECTATION) and also that she is capable of 
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quitting (EFFICACY EXPECTATION) (Strecher, Devellis, Becker, 
Rosenstock, 1986). 
It should be emphasized that efficacy expectations 
reflect a person's beliefs about capabilities and 
behavior-outcome links. Bandura (1982) maintains that 
efficacy expectations reflect a person's perceived, rather 
than actual, capabilities, and that it is these perceptions 
and not one's true abilities that often influence behavior. 
Bandura (1986) states that self-efficacy information is 
derived from four sources: enactive, or performance 
attainments; vicarious experience; verbal persuasion and 
physiological states. 
When the behavior change is believed to lead to desired 
consequences, but the change is difficult to make, 
self-efficacy considerations are probably paramount. 
Bandura (1982) states that self-efficacy influences all 
aspects of behavior, including the acquisition of new 
behaviors or the inhibition of existing behaviors. The 
self-efficacy construct has been examined in the area of 
smoking and smoking cessation studies through a variety of 
survey and experimental studies. survey studies of 
self-efficacy reviewed suggest strong associations between 
self-efficacy and behavior change progress, maintenance and 
relapse indicators. This research has been extremely 
helpful in delineating the role of efficacy expectations 
from outcome expectations as well as other psychological 
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constructs, such as stress and locus of control. Ratings of 
self-efficacy were found to discriminate active quitters 
from continued smokers, joiners of smoking cessation 
programs from non-joiners and successful from unsuccessful 
short- and long-term quitters. Experimental manipulations 
of self-efficacy suggest that self-efficacy may be enhanced 
and this enhancement is related to subsequent smoking 
cessation and reduction (Strecher et al. 1986). 
Investigations in smoking cessation strongly support 
the idea that the expectation of success and perceived 
self-efficacy are among the most important factors affecting 
smoker behavior change (Condiotte & Lichtenstein, 1981; 
DiClemente, 1981; Yates & Thain, 1985). Condiotte and 
Lichtenstein (1981) also demonstrated that ex-smokers 
self-efficacy ratings were situation-specific, i.e., their 
relapses occurred in situations where self-efficacy was 
lowest. In contrast, individuals who were able to maintain 
post-treatment abstinence were found to have higher 
self-efficacy scores than recidivists (DiClemente, 1981). 
Barrios and Niehaus (1985) showed that successful 
quitters reported higher self-efficacy than unsuccessful 
quitters. In addition, low self-efficacy has been shown to 
predict which smokers may relapse. Strecher et al. (1986) 
has shown in studies where other psychosocial constructs are 
examined, self-efficacy consistently emerges as a powerful 
predictor of behavior. It is important to understand that 
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the concept of self-efficacy relates to beliefs about 
capabilities of performing specific behaviors in particular 
situations, self-efficacy does not refer to a personality 
characteristic or a global trait that operates 
independently. This means that an individual's 
self-efficacy expectations will vary greatly depending on 
the particular task which confronts the individual (Strecher 
et al. 1986). 
Chronic illnesses which involve modifying lifelong 
behaviors require a good deal of confidence that one can, in 
fact, alter their lifestyles before such an intervention is 
possible. A growing body of literature supports the 
importance of self-efficacy in helping to account for 
initiation and maintenance of behavior change. In the realm 
of chronic diseases, much more emphasis is likely to be 
needed on skill training to enhance self-efficacy. Where 
complex behavior patterns are required to maintain or 
restore health, enhancement of self-efficacy will usually be 
required. This would certainly be the case in the 
modification of complex lifestyle practices such as 
cigarette smoking. 
Individual. Group and Self-Help Treatment Methods 
The interpersonal environment significantly influences 
cessation of smoking. Little research, however has been 
devoted to mobilizing social support as an intervention 
modality. Most of the smoking cessation research on the 
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to have the potential to improve main~enance of treatment 
effects at different points in the cessation process 
(Glasgow, Schafer, O'Neill 1981). Self-help intervention 
may appeal to smokers who would not participate in more 
intensive treatment (Pechacek, 1979). 
Poor follow-through under self-administered conditions 
is unfortunately a frequent characteristic of self-help 
behavior therapy programs. Pechacek (1979) has suggested 
that traditional group or individual treatments can possibly 
be used to supplement self-help interventions for the more 
recalcitrant smokers. Klesges et al. (1988) suggests the 
use of a stepped care approach. That is, perhaps lighter 
smokers might be treated differently (e.g. with self-help) 
than heavier smokers (who may be targeted for more intensive 
interventions group or individual sessions--once they have 
failed at a particular level). 
Therapist Contact 
It appears that the more complex the behavior change 
strategy, the more important the therapist. Glasgow et al. 
(1981) showed that therapist contact improved treatment 
effectiveness for the more detailed learning treatment 
program but that subjects in the more straightforward 
condition did as well on their own as they did with 
therapist assistance. Pechacek (1979) reported that the 
importance of a warm "client-therapist relationship" in 
successful smoking cessation. Glasgow et al. (1981) 
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topic has examined the effects of varying frequency and 
nature of therapist support. Results are contradictory and 
inconclusive. Some studies have evaluated the effects of 
group sessions vs individual counseling with neither 
approach demonstrating a clear-cut superiority (Windsor & 
Bartlett, 1984). 
Some people find the social support of a group 
especially appealing. Sirota et al. (1985) found that group 
members rated the influence and support of fellow 
participants and group leaders as two of the most helpful 
components of his study. 
One major conclusion of the 1979 Surgeon General's 
Report on Smoking and Health was that little is known about 
the millions of smokers who have quit on their own (U.S. 
Department of Health, Education and Welfare, 1979). It has 
been estimated that 95% of the over 30 million smokers who 
have quit since 1964 have done so on their own. If we know 
very little about how smokers quit on their own, less is 
known about ways to facilitate this self-help phenomenon. 
A large number of self-help smoking cessation manuals have 
been available commercially for years. Such approaches are 
believed to be worthy of scientific investigation because of 
easy availability, low cost, and possible client 
self-attribution of success rather than the therapist 
(Windsor et al. 1984). The role for self-help or minimal 
intervention is irrefutable. Self-help interventions appear 
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discovered that degree of therapist contact was associated 






The experimental design used in this study was repeated 
measures factorial design using a control group for 
comparison. Tobacco dependency and self-efficacy were to be 
used as covariates if homogeneity of regression occurred. 
This study was an experimental study because the independent 
variable of treatment was manipulated through random 
assignment. The study also had causal-comparative aspects 
because attributes such as being a normal smoker or having 
COPD, having high or low self-efficacy or high or low 
tobacco dependency have already occurred and cannot be 
manipulated. Correlational statistics were also applied to 
determine whether a relationship between the variables and 
smoking cessation outcome could be assessed. In effect, 
this study examined the effectiveness of three smoking 
cessation treatment methods in smokers who have COPD and 
normal smokers while trying to control for confounding 
variables verified by the literature review. This study was 
designed to answer the basic research question: What 




Graphic representation of study design. 
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Definition of Variables 
The dependent variables in this study were exhaled 
carbon monoxide levels and self-reported number of 
cigarettes smoked. Operationally defined, a non-smoker was 
any subject with a carbon monoxide level of less than 8 and 
abstinence of smoking for 7 days obtained from diary cards 
at the posttest. 
Smoking cessation therapy was manipulated as the 
independent variable. After determining smokers with COPD 
and those without subjects were randomly assigned to one of 
three treatment groups: 1) individual therapy, 2) group 
therapy, and 3) self-help therapy. 
Table 3.2 
Number of subjects in each cell. 
Normal COPP 
Individual Therapy 10 10 
Group Therapy 10 10 
Self-help materials 10 10 
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Other variables included demographic information such 
as age, sex, duration of smoking, pack-years, tobacco 
dependency scores, self-efficacy scores and smoking 
withdrawal symptoms of nicotine craving, irritability, 
frustration, anger, anxiety, difficulty concentrating, and 
restlessness. 
Main Effects 
There were three main effects in this study: l} time, 
2} group and, 3} treatment method. The main effects were 
organized into a 2x2x3 univariate factorial design. There 
were two levels of time, (pre-post}, two levels of group 
effect (normal smokers and COPD} and three levels of 
treatment effect, (individual therapy, group therapy, 
self-help therapy}. Again, the basic purpose of the study 
was to compare three levels of smoking cessation therapy in 
two groups of smokers before and after treatment. The 
treatment method effect is classified as a manipulative 
variable or instructor variable. In contrast, the group 
effect is an organismic or attribute variable. 
Smoking Cessation Therapist 
The smoking cessation therapist was a female Physician 
Assistant (graduate student and principal investigator} with 
over four years experience in pulmonary medicine and smoking 
cessation. Therapist training consisted of reading relevant 
background material. Therapy was standardized across groups 
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by following the American Cancer Society's FreshStart 
Facilitator's Manual. 
FreshStart Program 
FreshStart is a smoking cessation program sponsored by 
the American cancer Society and offered in various locations 
throughout the nation. The American Cancer Society's 
FreshStart Participant's Manual is a 16-page book with an 
accompanying 17-page Facilitator's Guide. The FreshStart 
Guide consists of four sessions intended to be given in four 
one-hour group sessions to take place twice weekly over a 
two-week period. The American Cancer Society follows the 
intended format. The FreshStart Facilitator's Guide 
suggests that although the above format is suggested, the 
program can be very flexible as long as the core curriculum 
is always presented. The FreshStart Facilitator's Guide 
contains a summary agenda and objectives for each session 
followed by details of the session's content. Each session 
includes four phases: (1) Individual Attention, (2) 
Strategies and Information, (3) Review and Discussion and 
(4) Assignments. 
Session I describes three aspects of smoking: 1) 
chemical addiction, 2) habit and 3) psychological 
dependence. It discusses approaches to stopping and 
physiological effects of smoking. The withdrawal symptom 
section of Session II was discussed at Session I in this 
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program since participants were asked to make the day after 
Session I their target quit smoking day. 
Session II focuses on progressive relaxation training 
including a therapist-led demonstration, assertiveness and 
constructive thinking. 
Session III asks subjects to identify and master all 
obstacles to staying off cigarettes. It follows with a 
discussion of weight management, alcohol and interpersonal 
support. 
Session IV asks participants to name any physical 
improvements they have experienced, describe main pitfalls 
and discuss the long-term benefits of staying smoke-free. 
Selection of Subjects 
Sixty adult cigarette smokers from a midwestern 
community were recruited from approximately 200 respondents 
via an advertisement in the Sunday edition of the local 
newspaper. Selection criteria included (1) being at least 
19 years of age, (2) expressing a sincere desire to quit 
smoking, (3) using no other forms of tobacco or nicotine and 
(4) having no other smoking household members. 
Participants were self-selected by their interest in a 
smoking cessation advertisement. All 200 respondents to the 
newspaper advertisement left their name and phone number on 
an answering machine. Respondents were called and given a 
general description of the program and selection criteria 
over the telephone. Each subject was asked if they had a 
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diagnosis of COPD/chronic bronchitis or if they have had a 
cough productive of mucous on most days of the week for at 
least three months of the year for the last two years 
(American Thoracic Society's definition of chronic 
bronchitis--U.S. Department of Health and Human Services, 
Smoking and Health, 1987). Respondents were told that this 
study was designed to look at the effectiveness of three 
smoking cessation treatment methods 1) individual therapy 2) 
group therapy and 3) self-help therapy·in smokers who have a 
productive cough and those who do not. They were told the 
study will involve five visits over four weeks and carried 
no financial obligations. 
Respondents who were eligible and willing to 
participate were divided into two groups: smokers without a 
productive cough (normal smokers group) and smokers with a 
productive cough (COPD group). Therefore, the sample of 
smokers was stratified based on symptoms and subjects were 
randomly assigned to treatment groups by stratum. Thirty 
subjects were randomly selected from each group by simple 
random sampling and scheduled for their first visit. 
Procedure 
At the first visit, subjects were instructed to read 
and sign two IRB-approved consent forms and keep one for 
themselves. Subjects were told that all records will remain 
confidential. They also completed the Demographic Pulmonary 
Assessment Profile, the Fagerstrom tobacco dependency 
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questionnaire and the Confidence self-efficacy 
questionnaire. In addition, subjects were asked to report a 
daily baseline number of cigarettes smoked and the duration 
of their productive cough. All subjects were asked to 
provide a sample of exhaled air to confirm that they were a 
smoker. Group assignments were made by having the subject 
randomly pick a slip of paper (one slip each for Individual, 
Group and Self-help) out of a bag which named which therapy 
the subject would get. Subjects were reminded that the 
therapist had no control over which therapy was chosen. 
Subjects were told if they were unsuccessful at their quit 
smoking attempt, they may try one of the other groups after 
four weeks. Regardless of which group was chosen, everyone 
received the American Cancer Society's Participants' manual 
and also Session I at the first visit. Initial intake 
meetings were with one to two s~bjects. Subjects were also 
instructed how to self-monitor their smoking and withdrawal 
symptoms using diary cards. Subjects were asked to target 
the next day as their quit smoking day and attempt to quit 
entirely. All subjects were given a beeper number to reach 
the therapist at anytime day or night for the entire four 
weeks. Subjects were encouraged to call the therapist if 
they had a severe craving for a cigarette or for any reason. 
Individual Therapy 
Twenty subjects (10 normal smokers and 10 smokers with 
COPD) who chose individual therapy met with the therapist 
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individually at weekly intervals for thirty minutes over the 
four week period. At each visit, the diary for the previous 
week was reviewed and new information from the next session 
in the FreshStart Manual was discussed. A sample of exhaled 
air was obtained for a carbon monoxide level and a new diary 
card was given for the next week. 
Group Therapy 
Twenty subjects (10 normal smokers and 10 with COPD) 
who chose group therapy met with the therapist in groups of 
four to six subjects at weekly intervals for one hour for 
the four week period. As with the individual treatment, at 
each visit, the diary for the previous week was reviewed and 
new information from the next session in the FreshStart 
manual was discussed. A sample of exhaled air was obtained 
for a carbon monoxide level and a new diary card was given 
for the next week. 
Self-help Therapy 
Twenty subjects (10 normal smokers and 10 with COPD) 
who chose self-help therapy received the American Cancer 
Society's FreshStart manual and Session I. The therapist 
asked each self-help subject to work through the remaining 
sessions on their own. They were scheduled for their next 
visit in four weeks and were given a reminder call the third 
week. Other than being able to contact the therapist at any 
time, the subjects did not have any organized sessions 
during the four-week program. At the final visit, subjects 
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returned their diary cards for the last four weeks, reported 
their experiences and were asked to provide a sample of 
exhaled air to assess carbon monoxide levels. Subjects who 
did not return for their final visit were called and asked 
if they had quit smoking, how many cigarettes they were 
smoking a day, and asked to return for an exhaled carbon 
monoxide level. 
Measures 
Self-monitored Diary Card 
Orleans and Shipley (1982) and Petitti, Friedman, and 
Kahn (1981) suggest that self-report has been recommended as 
the single most valid measure of smoking. The development 
of self-monitoring habits in a smoking program may 
facilitate the practice of other helpful behaviors learned 
during treatment. Self-monitoring may present the clearest 
form of continuous disruption of the smoking routine 
(Kamarck & Lichtenstein, 1988). This disruption may bolster 
awareness of smoking cues and confidence in ones' ability to 
control the smoking habit. Pomerleau et al.(1978) found 
that smoking abstinence at the end of an eight-session 
multicomponent treatment program was associated with a 
larger number of completed self-monitoring forms during the 
program. 
Subjects monitored number of cigarettes smoked and 
withdrawal symptoms on a daily basis throughout the 
four-week treatment program. Withdrawal symptoms were rated 
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time since smoking the last cigarette influence CO levels. 
Carbon Monoxide is eliminated primarily by the respiratory 
system; elimination half-life varies from 2 to 5 hours. 
False negative tests for cigarette smoking can occur if the 
subject has abstained from smoking for approximately eight 
hours or more prior to the test. False positive tests for 
cigarette smoking can occur in subjects who smoke marijuana, 
hashish, pipes or cigars. Exposure to cigarette smokers 
(i.e., "second hand smoke") can also produce a false 
positive test but is probably rare. (U.S. Environmental 
Protection Agency, 1979). 
End-expired air CO was measured using a portable, 
hand-held, battery operated instrument. Breath samples were 
analyzed pre-test and post-test using a Vitalograph Mini-co. 
Following the existing procedure manual, the Vitalograph 
Mini-CO was calibrated weekly by the therapist during the 
treatment period using CO monitor calibration gas. The 
calibration gas contains 50 parts per million (ppm) of 
compressed carbon monoxide. An accurate calibration check 
should read 50 +5 ppm within one minute. 
All carbon monoxide assessments were taken in the late 
afternoon or evening hours. Subjects were instructed to 
inhale deeply, hold their breath for 20 seconds and produce 
a full-forced expiration through a disposable sterile 
mouthpiece. Readings were recorded on the digital display 
area of the monitor in parts per million of carbon monoxide 
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on a scale of O=none (absent), l=slight, 2=mild, 3=moderate, 
4=severe. Withdrawal symptoms included craving for 
nicotine, irritability, frustration, anger, anxiety, 
difficulty concentrating and restlessness. Withdrawal 
symptoms and number of cigarettes smoked were summed and 
averaged across 1-week intervals to provide two measures: 1) 
average number of cigarettes smoked per day and 2) mean 
intensity of withdrawal symptoms. See Appendix D for diary 
card. 
Carbon Monoxide Levels 
An objective physiological index of recent cigarette 
smoking was obtained by determining the concentration of 
carbon monoxide (CO) in expired breath samples. Daughton et 
al. (1980), suggests that carbon monoxide is one of the most 
easily understood dangers for smokers and co intake may 
represent a more immediate risk, one that can be confirmed 
by feedback with a monitoring device. 
Approximately 10 to 20 ml of carbon monoxide is inhaled 
with each cigarette smoked. The co diffuses across alveolar 
membranes and once absorbed, is bound to hemoglobin. 
Carboxyhemoglobin in the blood is in equilibrium with 
alveolar air after breath-holding. Therefore, the amount of 
CO in expired air provides a rapid and accurate non-invasive 
measure of carboxyhemoglobin. 
The major limitation of using co as a measure of 
smoking behavior is that the time of day and the length of 
51 
within one minute. A typical non-smoker would produce a 
carbon monoxide recording of less than 8 ppm (corrected for 
ambient carbon monoxide). Smokers range slightly greater 
than 10 ppm in a non-inhaler to well over 75 ppm in heavy 
smokers. A carbon monoxide reading of 8 or greater 
(corrected for ambient CO) will categorize the subject as a 
smoker. This objective measurement corroborated patient 
reports of smoking cessation. 
Demographic Pulmonary Assessment Questionnaire 
The demographic questionnaire asks age, sex, duration 
of smoking, questions regarding a productive cough and 
categorical information on the number of packs smoked per 
day.In addition, the investigator asked the subjects for the 
actual number of cigarettes smoked and the duration of their 
chronic, productive cough if they reported having one. The 
latter information was important in dividing subjects into 
groups based on the American Thoracic Society's definition 
of chronic bronchitis. Subjects must have had a chronic, 
productive cough for at least two years to be in the COPD 
group. This information was not included on the 
questionnaire. Pack-year history was obtained by using the 
categorical information on the questionnaire and multiplying 
by the total number of years smoked. See Appendix E for the 
Demographic Pulmonary Assessment Questionnaire. 
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Fagerstrom Tobacco Dependency Questionnaire 
Fagerstrom (1978) developed an 8-item questionnaire 
aimed at estimating physical dependence on nicotine. The 
items cover various aspects of smoking behavior (number of 
cigarettes smoked per day, brand smoked, time of day smoking 
occurs, ability to control smoking in no-smoking areas and 
so on). Consistent and significant correlations from these 
indicators to the questionnaire (intended to measure 
physical dependence) have been established (Fagerstrom, 
1984). The higher the score on the dependence 
questionnaire, the higher the dependency. The range of 
scores of the questionnaire is from 0-11 with 0-6 considered 
low dependency scores and 7-11 as high-dependency scores 
(Fagerstrom, 1984). 
The Fagerstrom nicotine dependence scale enables 
patients to acknowledge their degree of dependence and to 
increase their general awareness of the dependency 
(addiction) concept and perhaps justify dependency as a 
cause of past quitting failures. See Appendix F and G for 
the Fagerstrom Tobacco Dependency Questionnaire and 
instructions for scoring. 
Confidence Self-efficacy Questionnaire 
Barrios and Niehaus (1985) showed that successful 
quitters reported higher self-efficacy ratings than 
unsuccessful quitters. This provides some validation for 
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the Confidence questionnaire as a screening device and as a 
rough predictor of likelihood of success in treatments. 
The Confidence Questionnaire is designed to assess the 
magnitude, strength and generality of self-efficacy 
expectations in smoking situations. A modified version of 
the questionnaire used by Condiotte and Lichtenstein (1981) 
will be employed in this study. Yates and Thain (1985) used 
the modified version to look at self-efficacy as a predictor 
of relapse following smoking cessation. The two items with 
the largest loadings on each of the seven clusters 
identified in a cluster analysis by Condiotte and 
Lichtenstein (1981) were used to construct the 15-item 
questionnaire (Yates, 1985). The items contain situations 
incorporating both intrapersonal and interpersonal mood 
states. 
Subjects will be instructed to designate on a 100-point 
probability scale (expressed in percentage units), ranging 
in 10 interval units, the probability that they would resist 
the urge to smoke in that situation. To provide an index of 
self-efficacy strength, the magnitude of expectancy scores 
across situations will be added and divided by the total 
number of items. Alpha reliabilities range from .69 
(interpersonal negative mood states) to .94 (intrapersonal 
negative mood states) (Baer and Holt, 1986). Examination of 
the psychometric properties of the Confidence questionnaire 
suggest it is highly reliable and primarily unidimensional. 
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This study compared the effectiveness of three smoking 
cessation treatment methods in two groups of smokers--normal 
smokers and smokers with COPD in an attempt to find the best 
"person-intervention-fit." As previously stated, the 
hypotheses for this study were derived from an extensive 
literature review. This review revealed evidence 
implicating tobacco dependency and self-efficacy as major 
determinants and supported the need for individualizing 
smoking cessation therapy. 
Cigarette smokers who answered a newspaper 
advertisement for a smoking cessation study were divided 
into two groups based on the presence or absence of a 
productive cough. Thirty smokers from each group were 
chosen by simple random sampling for a total of 60 subjects. 
Subjects were further randomized into one of three 
treatments: 1) Individual 2) Group or 3) Self-Help therapy. 
Ten subjects each from the normal smokers group and COPD 
group comprised the number in each treatment. 
Population Description CN=60) 
Twenty (33.3%) males and forty (66.7%) females 
participated in the study. As one group, the subjects 
averaged 39.667 (SD=ll.515) years of age, reported a mean 
smoking rate of 24.3 (SD=9.487) cigarettes per day at 
baseline, had smoked an average of 21.917 {SD=ll.053) years 
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and had a mean pack year history of 29.367 (SD=19.300). The 
60 subjects had a mean Fagerstrom tobacco dependency score 
of 6.667 (SD=l.838) and a mean self-efficacy score of 51.217 
(SD=l6.617). 
Description by Group Cn=30) 
Descriptive data for the two groups: normal smokers and 
COPD (n=30 in each group) is shown in Table 4.1. 
Table 4.1 
Means and Standard Deviations by Group for Age. Duration of 
Smoking, Pack-years, Tobacco Dependency and Self-efficacy 
Normal COPD 


























The thirty subjects in the normal smokers group, 9 
males (30%) and 21 females (70%) averaged 35.667 (SD=l0.479) 
years of age, reported a mean smoking rate of 24.833 
(SD=8.494) cigarettes per day at baseline, had smoked for an 
average of 17.500 (SD=9.909) years and had a mean pack-year 
history of 20.967 (SD=ll.775). The mean Fagerstrom score 
was 6.400 (SD=l.714) and mean self-efficacy score was 55.467 
(SD=14.438). The thirty subjects in the COPD group 
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11 males (36.7%) and 19 females (63.3%) averaged 43.667 
(SD=ll.263) years of age, reported a mean smoking rate of 
28.333 (SD=l0.565) cigarettes per day at baseline, had 
smoked an average of 26.333 (SD=l0.489) years and had a mean 
pack-year history of 37.767 (SD=l0.489). The mean 
Fagerstrom score was 6.933 (SD=l.964) and mean self-efficacy 
score was 46.967 (SD=17.775). 
As shown in Table 4.1, the majority of the means in the 
COPD group are higher with the exception of the 
self-efficacy scores. The lower self-efficacy means 
indicate that the COPD group had lower self-efficacy than 
their normal smoker counterparts. 
Description by Treatment Cn=20) 
Descriptive data for the three treatments: individual, 
group and self-help therapy (n=20 in each treatment) is 
shown in Table 4.2. Descriptively, it is interesting to 
note that the three treatment groups look very similar. 
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Table 4.2 
Means and Standard Deviations by Treatment for Age, Duration 
of Smoking, Pack-Years, Tobacco Dependency and Self-efficacy 
Therapy 
Individual Group Self-Help 
M SD M SD M SD 
Age 40.100 12.953 41.050 11.883 37.850 9.853 
Years Smoked 23.050 12.521 22.050 11. 395 20.650 9.472 
Pack-Years 31.400 20.582 27.650 19.754 29.050 18.312 
Tobacco Depen 6.050 1.820 6.350 1. 927 7.600 1.429 
Self-Efficacy ~4,900 19,200 53,850 12 ,001 44,900 16, ZZl 
Analyses of Research Hypotheses 
The hypotheses were analyzed by conducting tests for 
homogeneity of regression, discriminant analyses and. 
Chi-Square using the SPSSX program package. Further 
analyses using a 3-way, univariate, analysis of variance 
with repeated measures and its simple effects were conducted 
by using the BMDP program package. 
Classification of a Non-smoker 
Subjects were counted as non-smokers if they did not 
smoke during the last seven days of the study. The carbon 
monoxide cutting score for classifying smokers was set at 8 
parts per million (ppm), which is somewhat restrictive given 
Lando's (1975) finding that non-smokers can produce reading 
between 5 and 11 ppm. The carbon monoxide measure was used 
as the final standard if indicators seemed discrepant among 
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reported non-smokers. Evidence of a smoking episode during 
the last seven days resulted in the subject's classification 
as a smoker. 
Hypotheses 1: 
There will be no significant difference (R<.05) in 
pre/post mean exhaled carbon monoxide levels between 
treatment groups when therapy (individual vs group vs 
self-help) is manipulated in smokers with and without COPD. 
A test for homogeneity of regression using Fagerstrom 
tobacco dependency scores and Confidence self-efficacy 
scores was performed. Using a Wilk's lambda test, a 
significance level of .067 was reached which did not exceed 
the standard score of .10 for homogeneity of regression. 
Therefore, violation of homogeneity of regression occurred 
which was prohibitive for using these values as covariates. 
A split-plot analysis of variance for repeated measures 
using carbon monoxide levels was performed. The summary of 
the factorial analysis is shown in Table 4.3. As seen in 
this table, time was the only main effect that was found to 
be significant at R=.01. Thus, there was a statistically 
significant reduction in carbon monoxide levels 
pre-treatment to post-treatment. A two-way Timex Treatment 
effect was significant at R=.05. The remaining two-way 
interactions (Timex Group and Group x Treatment) were not 
significant. There was no three-way interaction effect. 
When comparing pre and post carbon monoxide levels, grouping 
effects were not found to be significant. 
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Table 4.3 
Spllt·Plot Analysis of Variance for Repeated Measures Using Pre and Post Carbon Monoxide levels. 
Effect OF SS HS F p 
GrOLp 1,54 44.40833 44.40833 0.46 0.4993 
T reat111ent 2,54 85.016667 42.508333 0.44 0.6445 
Time 1,54 2332.008333 2332.008333 31.34 0.0000* 
Timex Treatment 2,54 503.116667 251.558333 3.38 0.0414** 
GrOLp x Treatment 2,54 217.816667 108.908333 1.13 0.3291 
Timex Group 1,54 165 .675000 165.675000 2.23 0.1415 
Timex Group x Treatment 2,54 43.850000 21.925000 0.29 0.7460 
*Indicates statistical significance at R=.01 level. 
**Indicates statistical significance at R=.05 level. 
Post-hoc analyses were conducted to investigate the 
Timex Treatment interaction effect. Table 4.4 shows the 
means and standard deviations of pre-test and post-test 
carbon monoxide levels by treatment. 
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Table 4.4 
Means. Standard Deviations and Significance Levels of 
Pre-test and Post-test Carbon Monoxide CCO) Levels by 
Treatment. 
Therapy 
Individual*** Group**** Self-Help***** 
M SD M SD M SD 
Pre co 23.950 12.176 26.200 10.385 22.750 4.115* 
Post co 14.200 9.006 121200 8.065 19.350 9.483** 
*With 2,54 degrees of freedom, the F statistic was 0.65 
and 12=0.5280. 
**With 2,54 degrees of freedom, the F statistic was 3.08 
and 12=0.0540. 
***With 1,54 degrees of freedom, the F statistic was 
12.78 and 12=0.0007. 
****With 1,54 degrees of freedom, the F statistic was 
23.77 and 12=0.0000. 
*****With 1,54 degrees of freedom, the F statistic was 1. 55 
and 12=0.2100. 
An investigation of the simple effects was performed 
when holding time constant and looking across treatment. 
The probability level for mean pre-test carbon monoxide 
scores was 0.5280 and for mean post-test carbon monoxide 
scores was .0540. While this test did not reach statistical 
significance at 12=.05, it appears that there was a major 
difference between carbon monoxide values across all 
treatments pre-test to post-test. Further analysis 
investigated the simple effects when holding treatment 
constant and looking across time. Individual and Group 
therapy showed significantly different pre to post carbon 
monoxide levels than Self-help therapy. The change in co 
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levels pre-to post-treatment for Group and Individual 
therapy was more substantial whereas there was no apparent 
change in Self-help therapy. In this study, these two 
treatments (Individual and Group) appeared to be more 
effective than Self-help therapy. However, further 
differentiation between these two significant treatments is 
not possible. As seen in Table 4.4, the largest reduction 
in CO levels took place in the Group therapy, followed by 
Individual and then Self-help therapy. 
Hypothesis 2: 
There will be no significant difference (p<.05) in 
pre/post mean number of daily cigarettes smoked between 
treatment groups when therapy (individual vs group vs 
self-help) is manipulated in smokers with and without 
COPD. 
A split-plot analysis of variance for repeated measures 
using number of cigarettes smoked was performed. Table 4.5 
shows a summary of the factorial analysis. Time was a 
significant main effect at p=.01. Group main effect was 
also significant at p=.05. Treatment effect was not 
significant. There were no interaction effects. 
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Table 4.5 
Split-Plot Analysis of Variance for Repeated Measures Using 
Pre and Post Number of Cigarettes Smoked. 
Effect DF SS 
Timex Group x Treatment 2.54 0.466667 
MS F p 
725.208333 6.15 0.0163** 
264.533333 2.24 0.1161 
6735.008333 100.92 0.0000* 
74.033333 1.11 0 I 3372 
261.733333 2.22 0.1187 
60.208333 0.90 0.3464 
0.233333 0.00 0 ! 9965 
Group 1,54 725.208333 
2,54 529.06667 Treatment 
Time 1,54 6735.008333 
Timex Treatment 2,54 148.066667 
Group x Treatment 2,54 523.466667 
Timex Group 1,54 60.20833 
*Indicates statistical significance at R=.01. 
**Indicates statistical significance at R=.05. 
Table 4.6 shows the means and standard deviations of 
the number of cigarettes smoked at baseline and after 
treatment. All 60 participants in this study were clearly 
able to reduce the number of 
cigarettes smoked. 
Table 4.6 
Means and Standard Deviations of Pre/Post Number of 
Cigarettes Smoked. 
Time 
Pre <N-60) Post (N-60) 
M SD M SD 
Number of Cigarettes Smoked 26.583 9.666 11. 600 10.456 
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Table 4.7 shows the means and standard deviations for 
pre/post number of cigarettes smoked by Group. Normal 
smokers were able to reduce their cigarette number by 
slightly more than smokers with COPD. Also seen in Table 
4.7, smokers with COPD smoked more than normal smokers. 
Table 4.7 
Means and Standard Deviations for Pre/Post Number of 
Cigarettes Smoked by Group. 
Group 
Normal Smokers (n-30) COPD (n-30) 
M SD M SD 
Pre number of cigarettes smoked 24.833 8.494 28.333 10.565 
Post number of cigarettes smoked 8.433 8.585 14.767 11.313 
Hypothesis 3: 
There will be no difference in the frequency of success 
between groups when therapy is manipulated. 
Using a Chi-Square statistic for normal smokers and 
COPP, it was found that in neither group was there a 
significant relationship between treatment and smoking 
cessation outcome over chance. Table 4.8 and 4.9 show the 
frequencies and percentage quit rates by Treatment for the 
two groups. In the normal smokers group, 26.7% of the 
subjects successfully quit smoking, whereas, 20% of the COPD 
group were able to quit. 
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Table 4.8 
Frequency Distribution of Smoking Cessation Outcome by 









8 (26. 7%) 
_8 _ 
22 (73. 3%) 
Table 4.9 
Frequency Distribution of Smoking Cessation Outcome by 
Treatment for the COPD Group. 
Non-smokers Smokers 
Individual (n=lO) 3 7 
Group (n=lO) 2 8 
Self-help (n=lO) _ 1_ _9 _ 
TOTAL Cn=30l 6 (20%) 24 (80%) 
Hypothesis 4: 
There will be no relationship between demographic 
variables and smoking cessation outcome between groups. 
Hypothesis 5: 
There will be no relationship between tobacco 
dependency and smoking cessation outcome between groups. 
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Hypothesis 6: 
There will be no relationship between self-efficacy and 
smoking cessation outcome between groups. 
Hypotheses 4, 5, and 6 were tested using a discriminant 
analysis. The analysis showed that no combination of 
overall self-efficacy scores, tobacco dependency scores, 
duration of smoking, pack-year history and pre-study 
baseline smoking rate could differentiate those who would 
quit smoking from those who would not. (With 5 degrees of 
freedom, Wilk's lambda was .856 and p=.1249). The percent 
of grouped cases correctly classified as a smoker using 
these variables was 69.6%. The percent of grouped cases 
correctly classified as non-smoker was 71.4%. See Appendix 
I for means and standard deviations of self-efficacy and 
tobacco dependency by group. 
Hypothesis 7: 
There will be no relationship between smoking cessation 
withdrawal symptoms and outcome between groups. 
A discriminant analysis for comparisons among normal 
smokers and COPD were performed on seven smoking cessation 
withdrawal symptoms: 1) nicotine craving, 2) irritability, 
3) frustration 4) anger, 5) anxiety, 6) difficulty 
concentrating and 7) restlessness. The discriminant 
analysis showed that only two variables (anxiety and 
restlessness) in combination could predict smoking cessation 
outcome at the p=.05 level, (p=.0279). When comparing the 
two groups, smokers with COPD had higher anxiety (2.067 ± 
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1.163 vs 0.889 ±0.832) and higher restlessness {2.533 ± 
0.990 vs 1.000 ± 0.970) than non-smokers during the program. 
See Appendix J for means and standard deviations of the 
withdrawal symptoms by group. 
Attrition 
In this study, attrition was a major influencing 
factor. While all post-test carbon monoxide measures were 
obtained either at the time of discontinuation or at the 
completion of the study, it is interesting to note the 
attrition rate in Table 4.10. 
Table 4.10 
A Comparison of Weekly Attrition Rates Between Normal 
Smokers, COPD and Individual, Group Therapy. 
Group Treatment 
{n=30) {n=30) (n=20) (n=20) 
Normal Smokers COPD Individual Group 
Visit 2 10.0% 23.3% 10.0% 40.0% 
Visit 3 6.7% 6.7% 10.0% 10.0% 
Visit 4 16.7% 10.0% 40.0% ~ 
TOTAL 3~s4l 40.0l 60.0l 50.0l 
Table 4.10 shows the weekly attrition rates by group 
and by treatment respectively. While the comparison of 
total attrition percentages in the table appear to be 
similar, it is interesting to note the large dropout rate at 
Visit 2 in both the COPD group and Group treatment. Thus, 
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Group therapy experienced a large initial drop in 
membership. In this study, smokers with COPD and members of 
Group therapy were most likely to discontinue early. 
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CHA.Pl'ER FIVE 
DISCUSSION AND SUMMARY 
Summary 
The present study randomly assigned normal smokers and 
smokers with COPD to one of three smoking cessation 
treatments. The following is a discussion and summary of 
the findings: 
This study showed significant mean decreases in both 
the number of cigarettes smoked and carbon monoxide levels 
for all subjects in the program. Twenty-seven percent 
(8/30) of the subjects in the normal smokers group 
successfully quit smoking. In contrast, 20% (6/30) in the 
COPD group were able to quit. These results are consistent 
with current nonpharmacological smoking cessation programs. 
The assumption of the investigator that there would be 
a difference between normal smokers and smokers with COPD 
was not supported. The two groups had roughly the same quit 
rates, however in number of cigarettes smoked, there was a 
significant group difference pre-test to post-test. Normal 
smokers were able to reduce the number of cigarettes smoked 
more noticeably than the COPD group. Based on the 
understanding of the review of the literature, a larger 
effect was expected. This chapter focuses on some possible 
explanations that could explain these results. 
In discussing program evaluation, Green (1980) talks 
about sleeper effects. He suggests that health educators 
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often do not put enough effort into health education 
programs. If it is lifestyle change that we're after, 
health education programs may get the process started but 
because measurements may be poor or infrequent, we don't 
realize the trend is going on and we only measure it at a 
couple points in time. Even though an effect is not 
established at the end of the program, indeed it may happen 
later on. Too frequently, we pull out before we can 
actually see what has happened. 
There are two ways to explain the results of this 
study: 1) It is possible that there was an effect but it 
was not capable of being measured based on: the right 
instrument was not used, the effect was not measured with 
enough precision, the effect was not measured often enough 
or over a long enough period of time. The other explanation 
is 2) there was not an effect, given the situation, given 
the subjects, in that environment with that intervention 
that there was not a difference between those conditions. 
Discussion of Group Effects 
It was disappointing that none of the demographic 
variables, tobacco dependency scores or self-efficacy scores 
were able to predict smoking cessation outcome, within the 
groups. With such small samples, a few extreme scores could 
have skewed the results. It is possible that if a larger 
sample would have been used that a greater group 
relationship may have been established. For this study, 
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however, the two groups (normal smokers and COPD) were 
largely the same. While the mean values for each variable 
were generally higher for the COPD patient, both groups 
smoked about the same number of cigarettes at baseline, had 
about the same pack-year history and duration of smoking and 
had about the same pre-study carbon monoxide levels. The 
only difference between these two groups was the subjective 
claim of a chronic, productive cough at least for two years 
in the COPD group. It is apparent from the data that all 60 
subjects were more homogeneous than the investigator had 
planned. A more heterogeneous group with a wider variety of 
smokers may have provided for a better expression of the 
group effect. This finding also colors the effect of the 
type of smokers in each treatment group. Group therapy had 
a large initial dropout rate, probably due to the 
homogeneity of the group. 
The investigator believes that there were differences 
among the two groups but that they were not measured. 
Instead these differences were based on personal 
observation. If we look at number of self-reported 
cigarettes smoked and carbon monoxide readings, it is 
surprising that these values are somewhat identical--which 
would tend to support that self-report and physiological 
functions will come out fairly close together. Therefore, 
if people are giving a voluntary definition of a COPD 
patient based on a chronic cough, then we best accept it. 
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But to say that the subjects who have symptomatic complaints 
are the same as a group of people who don't profess to have 
a chronic cough is ridiculous. A possible way to create 
larger differences between groups, was to have included 
spirometrical criteria for eligibility criteria so as to 
further define COPD patients with loss of lung function. 
For some reason, these groups looked a great deal alike, but 
one of them was obviously different because they were 
reporting that they were coughing all the time and the other 
group was not. 
The overall attrition rate was 37% in this smoking 
cessation program, however both normal smokers and COPD had 
approximately the same percentages. Some smoking cessation 
programs in the literature use a commitment fee or a deposit 
to increase program adherence. This research did not use 
this strategy, although if used, it may have had an effect 
on the attrition rate and should be considered for future 
studies. Given that cigarette smoking is a highly 
refractory behavior, the attrition rate is not surprising. 
As the program evolved, though, it was fascinating to watch 
the drop-out rate and listen to the various reasons for 
discontinuing the program. This was especially interesting 
in the COPD group where 40% of the participants discontinued 
by Visit 2. This high early attrition rate in this group 
could be due to the fact that these smokers are more highly 
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addicted, smoked for a longer number of years and had more 
previous smoking cessation attempts. 
We should remember that the smokers in the COPD group 
were experienced. After a number of attempts at quitting, 
they could tell within the first week if this attempt was 
going to be successful. All of those participants who 
dropped out at Visit 2 had already gone back to smoking. 
Perhaps the environment was not right for them to quit 
smoking at this time. This could be explained in terms of 
Bandura's outcome expectation. Most smokers will say that 
they can quit if given the right circumstances. Once they 
get into a program and begin believing that, for various 
reasons, the time is not right for them to quit, damage to 
their outcome expectations may already occur. In this 
scenario, self-efficacy expectations may not be as important 
as outcome expectations which can change just as rapidly as 
self-efficacy. 
The major reasons for discontinuation was the fear of 
talking about smoking within a group situation. This did 
not seem to be a major factor with the participants in 
individual therapy. Perhaps this is an example of the way 
illness behavior influenced this study. For example, 
perhaps patients with COPD have a narrow range within which 
they can tolerate anxiety, and these patients may be unable 
to tolerate the emotional stress caused by group 
discussions. However, these patients may be able to 
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tolerate carefully managed individual counselling. Patients 
with COPD who have socially isolated themselves in response 
to their illness may be extremely uncomfortable in talking 
about their smoking cessation efforts (Dudley et al. 1985). 
The social unease and stiffness that accompanies getting 
acquainted, not knowing what to expect, feeling a great deal 
of anxiety is an undue source of tension in these patients. 
Since both normal smokers and smokers with COPD were members 
of the same group and expected to interact together, it 
could be that subjects labelled as COPD and thrown into a 
group of asymptomatic smokers were thinking, "They don't 
know what it is like to be like me.11 If we think about 
group anxiety and COPD in terms of the Health Belief Model 
and its relation to chronic illness (Kasl, 1974), no amount 
of susceptibility, seriousness or perceived benefits may be 
able to overcome these barriers to achieve behavior change. 
Group dynamics are an integral part of any group 
smoking cessation therapy. Understanding group behavior in 
secondary groups (groups that are task-oriented) is 
necessary for promoting cohesiveness with in the group. 
Cohesiveness refers to how strongly members want to remain a 
part of the group and comply with group norms (Bormann, 
1975). Researchers have shown that groups high in 
cohesiveness have greater rates of interaction and have less 
attrition (Brilhart, 1986). For this reason, smoking 
cessation within primary groups, such as work groups and 
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families are thought to be more effective than participants 
who are unfamiliar to each other. 
Discussion of Measures 
The Confidence Self-efficacy questionnaire and the 
Fagerstrom Tobacco Dependence questionnaire demonstrated no 
predictive validity. In this study, tobacco dependency and 
self-efficacy scores were not predictive of outcome. Due to 
the high standard deviations of these values, it appeared 
that these measures had little more than face validity. 
With regard to the self-efficacy effect, implications 
for medical management are that the health care professional 
should have some means of interpreting how a patient 
perceives himself/herself to optimize behavior changes. For 
example, if the subject had low self-efficacy scores, then 
the health care professional must look for ways to improve 
the subjects' self-efficacy before beginning a smoking 
cessation program. Self-efficacy training is a tremendous 
opportunity for health educators. Without self-efficacy 
training, we may be setting smokers up for failure because 
we have not prepared them well. 
Discussion of Health Effects 
Many patients who did not give up cigarettes completely 
reported substantial reductions in the amount smoked. Time 
effects for both mean carbon monoxide levels and mean number 
of cigarettes smoked were seen indicating significant 
reduction pre-test to post-test. From the perspective of 
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preventive medicine, reductions of this magnitude may 
represent significant levels of impact in the health of all 
patients (Windsor et al. 1980). Statistical significance 
and practical significance are not always the same thing. 
One issue is that getting smokers to reduce the amount 
that they smoke may not all be beneficial to their health, 
but it is beneficial if they are serious about it as being a 
step in the process of quitting. If we can get their 
addiction levels down to the point where there are not a lot 
of physiological problems along with the psychological 
problems of quitting, then a stepwise approach is clearly 
worth investigating. Almost all of the self-help books 
discuss the various strategies for quitting. These 
strategies include cold turkey and also two methods of 
reducing cigarettes as a means to stop. These two methods 
are 1) tapering and 2) postponing. Tapering simply means 
cutting down the total number of cigarettes each day until 
Quit Day and postponing is waiting until a progressively 
later time each day to have a cigarette until Quit Day. 
Let's look at the carbon monoxide (CO) data in terms of 
clinical significance. It is known that as blood 
carboxyhemoglobin (COHb) levels increase, health effects 
become more severe (U.S. Environmental Protection Agency, 
1979). Heart and lung functional changes are associated 
with COHb levels greater than 5%, which corresponds to 
approximately 27 PPM co in exhaled air. In the present 
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study, the group means are well above this level before 
treatment and consistently below at the end of treatment and 
at follow-up and therefore demonstrates practical 
significance. The weekly feedback of co levels in the 
individual and group therapy, which may have provided early 
evidence of success, was commented on as being helpful by 
the members of the individual and group therapy. 
It was observed that several of the subjects reported 
having lost or misplaced some of the diary cards. There 
were no discrepancies between self-reported number of 
cigarettes smoked and carbon monoxide levels. Therefore, 
self-report on the diary cards are assumed to be reasonably 
valid indicators of actual behavior in this sample. 
The fact that individual and group therapy were 
significant over self-help therapy justifies the expense of 
inputs into an intensive smoking cessation program. Staff 
time, resources and training materials can be significant 
items of expense in any program. In this study, it was 
shown that such an expense was worthwhile in being able to 
change smoking behavior. 
This study employed smokers that were voluntarily 
asking to become quitters. Even the self-help treatment 
group showed some success, although not much. However, 
self-help interventions may still be justified on a 
cost-effective basis for some smokers (Glasgow et al. 1981). 
It is true that the Self-help group did not do as well as 
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Individual or Group therapy, but we should not expect much 
success given that it is an inexpensive treatment. However, 
smoking is an important and expensive health problem. Even 
small steps toward solving the problem can be beneficial. 
From this standpoint, one might begin with a 
self-administered program, and follow with a more complex, 
multicomponent behavior therapy program administered by a 
therapist. 
Limitations of the Study 
These results must be seen as specific for this 
population and interpreted with caution. Limitations 
include the small number of subjects, lack of control and 
the absence of even longer follow-up data. Although the 
present study was useful in recruiting participants, 
attrition rates are high and outcome modest. The cell sizes 
were quite small and thus the reader is cautioned about 
overgeneralizing from the results. 
This study shares limitations with other evaluations of 
smoking cessation programs. To study users of a program 
effectively, experimental contact should have been provided 
beyond the program alone (6 week, 2 months, 3 months, 6 
months, 1 year). Follow-up was not included in this study. 
As much as one can control for nuisance variables, no 
experimental treatment is exactly alike for every subject in 
a particular condition. Environmental changes such as 
temperature, noise level, interruptions and inconsistent 
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performance of the smoking cessation therapist are all 
possible variables that may have affected this study. All 
attempts were made to control as many confounding variables 
as possible. Under normal conditions, it was expected that 
extraneous variables would operate equally. 
One of the largest threats to internal validity in this 
study was experimental mortality. Every effort made to 
emphasize the importance of continuing all sessions in an 
attempt to reduce attrition. Subjects were encouraged to 
continue therapy sessions even if they had smoked with the 
hope that they would quit yet before all sessions were 
completed. If subjects did not return for their post-test 
carbon monoxide levels, the post-test number of cigarettes 
smoked was obtained by self-report, either verbally or by 
diary. For those subjects who did drop out of therapy, the 
number, type of group the subject was in and the reason for 
discontinuation were all recorded. 
The investigation was limited only to twenty subjects 
in each treatment group and ten in each cell because of lack 
of funding and personnel. However, this sample was believed 
to be large enough from which to draw conclusions, or at 
best, trends. 
All therapy sessions were conducted by the principal 
investigator so that inter-investigator training for smoking 
cessation therapy was not needed. In addition, the 
investigator attempted to refrain from displaying any study 
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expectancies. The American Cancer Society's FreshStart 
Facilitator's Guide was used as the investigator's manual to 
ensure uniform counseling. Of the measures of the dependent 
variable, only number of cigarettes smoked since Quit Day 
and withdrawal symptoms were self-reported on the diary 
cards. Exhaled carbon monoxide is a physiological test of 
smoking cessation. Therefore, because there was no 
observational recording of the dependent variable in this 
study, there was not an opportunity for observer bias to 
occur. 
The investigator was disappointed in the value of the 
demographic questionnaire. It became evident that important 
information was not included and the investigator had to ask 
each and every subject for continuous data on the daily 
number of baseline cigarettes (the questionnaire asks for 
categorical data) and the duration of a self-proclaimed 
productive cough. Retrospectively, interesting information 
such as number of previous quit smoking attempts could have 
been obtained and analyzed to see if that might have had an 
effect on outcome between the two groups. 
Other information that could have provided a stronger 
study would have been to obtain a baseline diary one week 
before Quit Day to objectively report the daily baseline 
number of cigarettes smoked rather than pure verbal 
self-report. 
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As previously mentioned, other limitations included 
ethical issues involving the self-help group. Therefore, 
any of the participants who were still smoking at the end of 
the study were offered treatment of their choice after the 
experiment was concluded. This was thought to provide an 
"internal" replication of the experiment as the self-help 
group could be compared with itself (before and after 
receiving the treatment). Unfortunately, none of the 
subjects asked for alternate forms of therapy. The 
investigator believes that during the four weeks of the 
treatment period, subjects were genuinely motivated and 
tried very diligently to follow program principles. After 
the program was over, however, it appeared that the stress 
of remembering not to have a cigarette and the constant 
struggle with temptation was too much to bear. It didn't 
seem to be the fact that they didn't want to quit again but 
just that they needed "a break." Perhaps, their too-recent 
experience of their attempt to quit smoking and failure 
damaged their self-efficacy beyond the point of readiness 
for another program right away. Again, useful data to have 
collected would have been the total number of attempts at 
quitting to see if this may have correlated. 
Although one might wish to generalize the findings of 
this study to "all" smokers, strictly speaking we can 
generalize only from which the sample was drawn. In 
addition, various personological variables may affect the 
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generalizability of findings from this experiment--further 
classification of gender, extroversion-introversion, locus 
of control and illness behavior as well as many other 
factors characterizing smokers could have affected the 
results of this study. This study attempted to control for 
initial differences by incorporating control factors in the 
statistical analysis. Self-efficacy and tobacco dependency 
were tested using homogeneity of regression for their 
utility as covariates. Homogeneity of regression was not 
supported. Thus, the two groups were heterogenous with 
regard to these factors. 
One threat to internal validity in this study is the 
unreliability of the measures (self-efficacy scores and 
tobacco dependency scores) which were to be used as 
covariates to control for initial differences between 
groups. One possible explanation for the lack of 
homogeneity for these two variables is the tests used to 
measure tobacco dependency and self-efficacy. A good 
instrument is one that differentiates between subjects. The 
usefulness of a questionnaire depends on its 
responsiveness--that is, its ability to detect clinically 
important changes, even if the changes are small (Guyatt et 
al. 1985). Because "construct validity" was unable to be 
used due to lack of a comparable standard for self-efficacy, 
"face validity" was relied upon. Better development of 
self-efficacy measures in the future may provide for more 
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predictive validity. As for tobacco dependency, past 
research has indicated that the Fagerstrom Tobacco 
Dependence questionnaire does have predictive capabilities. 
In this study, tobacco dependency scores were the closest to 
significance than any of the other variables used in the 
discriminate analysis. Therefore, one can probably dismiss 
the lack of predictive validity for tobacco dependency 
scores as due to sampling error. The sample may have been 
too small, there may have been a few erratic scores and the 
standard deviations were too wide that the tobacco 
dependency score was unable to predict. 
Future Research 
Future research should address the types of smokers who 
are likely to be attracted to alternative, potentially 
cost-effective approaches. Future research is still needed 
in developing effective smoking cessation programs for 
smokers dealing with cigarette-related chronic illnesses. A 
study using pharmacological therapy such as the Nicorette 
gum would be beneficial in smokers with COPD. Illness 
behavior is a complex medical phenomenon. As we develop 
programs for those already diagnosed with an illness, we 
need to think about the effect that illness behavior may 
have on the program. Further characterization of behavior 
in illness is needed. It may be of value for researchers in 
smoking cessation to study how group cohesiveness can be 
fostered. Future research is also needed to understand the 
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nature of adherence rates in self-administered programs 
(Glasgow et al. 1981). Clearly, additional research in all 
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CONSENT FORM 
A COMPARISON OF SMOKING CESSATION METHODS IN NORMAL SMOKERS AND 
SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
Invitation To Participate 
We invite you to participate in a research study comparin9 
the e!!ectiveness o! three smokin9 cessation treatment methods. 
Basis For Sub1ect Selection 
You have been selected to participate in this study because 
you are a cigarette smoker, over 19 years of age, who is ready to 
stop smoking. No other forms of tobacco or nicotine other than 
cigarettes will be allowed. There will be 60 participants 
enrolled in this study. 
Purpose Of The Study 
The purpose of this study is to compare the e!!ectiveness o! 
three types o! smoking cessation methods in di!!erent types of 
smokers. 
Explanation Of Procedures 
This study will take !our weeks to complete. The !ollowin9 
are the procedures you will undergo as a subject in this study: 
Study Visit 1 
You will be randomly assigned (similar to !lippin9 a coin) 
to one of three treatment groups: 1) individual therapy; 2) 
group therapy; or, 3) given only the manual and asked to return 
at the end o! the study. Visit 1 will require 30 minutes. To 
confirm your smoking history, you will be asked to complete some 
questionnaires and provide a sample o! expired air (for assessing 
carbon monoxide levels). There will be three questionnaires. 
One questionnaire will give us some basic information about you, 
your smoking history and your lung status. Another will give us 
an idea of how dependent you are on nicotine. The last 
questionnaire describes situations where people frequently smoke. 
Subject's Initials 
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Uncoln, NE 6858$-0229 
You will be asked to rate the probability to resist the urge to 
smoke if the situation arises. Carbon monoxide is found in 
cigarette smoke. In order to determine whether or not you are a 
cigarette smoker, you will be asked to hold your breath for 20 
seconds then exhale through a mouthpiece into the carbon monoxide 
machine. At the end of this visit, you will be given a manual to 
help support your quitting efforts. Your quit-smoking day will 
be the next day, and you will be asked to quit entirely. 
Study Visit 2-5 
If you are assigned to individual or group therapy, you will 
be asked to return weekly for four more counselling sessions. 
Group therapy will take approximately one hour, and individual 
therapy sessions will take about 30 minutes. You will be given 
diary cards to keep track of withdrawal symptoms. At each of the 
remaining visits, we will collect your diary cards, and you will 
provide us with a sample of expired air to confirm your smoking 
status. While participating in this study, you must refrain from 
using any other form or method of smoking cessation. If you were 
assigned to the self-help treatment method, you will be contacted 
after !our weeks to determine whether or not you are smoking. 
All subjects who are unsuccessful will be offered an alternate 
therapy of their choice, 
Potential Risks Alld Discomforts 
There are side effects associated with quitting smoking. 
These include headache, sleep disturbance, irritability, anxiety, 
upset stomach, impaired concentration, frustration, depression 
and weight gain. 
Potential Benefits 
You may not receive any direct benefit from participating in 
this study. A potential benefit of participating in this study 
is the possibility that you may stop smoking. However, we cannot 
guarantee that the study will enable you to stop smoking. In 
fact, regardless of the treatment you receive, you will still 
have to try very hard in order to stop. Your efforts, however, 
may lead to new methods for treating tobacco dependence. 
Subject's Initials 
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Alternatives To Participation 
Alternative and partially effective ways to treat tobacco 
addiction already exist. These alternatives, dependinq upon your 
physician's recommendation, may include formalized atop-smokinq 
pro9rams or stoppinq cold-turkey. 
Financial Obligations 
There are no financial obli9ations to you for participatinq 
in this study, 
Compensation for Participation 
There are no economic incentives or extrinsic rewards for 
participation in this study. It is hoped that a successful 
attempt at smoking cessation will be its own reward. 
Assurance Of Confidentiality 
Any information obtained durinq this study which could 
identify you will be kept strictly confidential. The information 
obtained in this study may be published in scientific journals or 
presented at scientific meetinqs, but your identity will be kept 
strictly confidential. 
Withdrawal from The Study 
Participation is voluntary. Your decision whether or not to 
participate will not affect your present or future relationship 
at the University of Nebraska. If you decide to participate, you 
are free to withdraw from this study at any time. 
If any new information develops durinq the course of this 
study that may affect your willinqness to continue participatinq, 
you will be informed immediately. 
Offer To hoswer Questions 
If you have any questions, please do not hesitate to ask, 
and they will be answered at this time. If you think of any 
additional questions later, please feel free to contact one of 
the investiqators listed below. 
Subject's Initials 
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Phyeical Education and Recreallon 
l.Jncx>ln, NE 68!>88·0229 
If you have any questions concerninq your ri9ht1 ••a research 
subject, you may contact the University o! Nebraaka Institutional 
Review Board (IRB), telephone 402/559-6463. 
YOU ARE VOLUNTARILY MAKING A DECISION WHETHER OR NOT TO 
PARTICIPATE IN THIS RESEARCH STUDY. YOUR SIGNATURE CERTIFIES 
THAT YOU HAVE DECIDED TO PARTICIPATE HAVING READ AND UNDERSTOOD 
THE INFORMATION PRESENTED. YOUR SIGNATURE ALSO CERTIFIES THAT 
YOU HAVE HAD AN ADEQUATE OPPORTUNITY TO DISCUSS THIS STUDY WITH 
THE INVESTIGATOR, AND YOU HAVE HAD ALL YOUR QUESTIONS ANSWERED TO YOUR SATISFACTION. YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM 
TO J<EEP. 
Signature of Subject Date 
HY SIGNATURE AS WITNESS CERTIFIES THAT THE SUBJECT SIGNED THIS 
CONSENT FORM IN HY PRESENCE AS HIS/HER VOLUNTARY ACT AND DEED. 
Signature of Witness Date 
IN MY JUDGEMENT, THE SUBJECT IS VOLUNTARILY AND KNOWINGLY GIVING 
INFORMED CONSENT AND POSSESSES THE LEGAL CAPACITY TO GIVE 
INFORMED CONSENT TO PARTICIPATE IN THIS RESEARCH STUDY. 
Signature of Investigator Date 
Investigators: 
Mary Mueller, PA-C 
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Study Case Number: 
Participant's Initials: 
DEMOGRAPHIC PULMONARY ASSESSMENT PROFILE 
Dear Participant: 
Please answer the following questions as they pertain to your 
general health: 
1. What.is your age? 
2. Are you: Hale Female 
3. Do you currently smoke: 
Less than 1/2 pack per day 1/2 to 1 pack per day 
1-2 packs per day Over 2 packs per day 
Current brand: 
4. Total years smoked in all? years 
5. Do you have an intermittent cough 
(not related to a common cold)? 
Yes No 
6. Do you frequently cough in the morning? Yes No 
7. Is y~ur cough related to mucus in 
your chest or throat? Yes No 
8. Do you experience intermittent 
chest congestion? Yes No 
9. Oo you have shortness of breath? Yes No 
10. I! yes, when? 
During strenuous exercise ~-During moderate exercise 





THE FAGERSTROM NICOTINE 
TOLERANCE SCALE 
SCN: 
PLEASE CIRCLE THE APPROPRIATE RESPONSE A (0) B (1) c (2) 
1, HOW SOON AF"TER YOU WAKE UP DO YOU An[R 30 MIN WITHIN 30 MIN -- SMOKE YOUR rlRST CIGARETTE? 
2. DO YOU rlNO IT DIFTICUL T TO RErRAIN 
FROM SMOKING IN PL.ACES WHERE IT IS NO YES -- f"ORBIOD(N, SUCH AS THE LIBRARY, 
THEATER, DOCTOR'S orncE? 
ANY OTHER TH( rlRST ONE 
3. WHICH or ALL THE CIGARETTES YOU SMOKE THAN TH( IN TH( -- 
IN A DAY IS TH( MOST SATISF"YING ON(? rlRST ON( IN MORN IN() 
THC l.IORNINC 
'· HOW "4ANY CIGARETTES A DAY 00 YOU 1-15 16-25 MORE SMOKE:? THAN 25 
5. 00 YOU SMOKE "40RE DURING THE MORNING NO YES -- THAN DURING THE REST or THE DAY? 
6. 00 YOU SMOKE WHEN YOU ARE SO ILL NO YES --· THAT YOU ARE IN BED MOST or THE DAY? 
7. DOES THE BRANO YOU SMOKE HAV( A L6W, LOW MEDIUM HI~ MEDIUM, OR HIGH NICOTINE CONTENT? 
(0 ..... 00 ""' co•• ... - ·~1 CWC\" ':f" 
8. HOW orrr« DO YOU INHALE THE S"40KE N[V(R SOMETIMES ALWAYS rROM YOUR CIGAREnE? 
ASSIGN NO POINTS f"OR EACH ANSWER IN COLUl.AN A. 1 POINT f"OR EACH ANSWER IN 
COLUMN B. ANO 2 POINTS rOR EACH ANSWJR IN COLUl.AN C (NOTE THAT NOT ALL 
OUESTIONS HAVE AN ANSWER IN COLUMN c . TH[N, TOTAL TH[ NUMBER or POINTS 
TO ARRIVE AT THE rACERSTROM SCOR(:. T E HIGHEST POSSIBLE SCORE IS 11. 
I I TOTAL SCORE: 
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APPENDIX G 
SCORING OF FAGERSTROM TOBACCO DEPENDENCE QUESTIONNAIRE 
Each completed Fagerstrom Tobacco Dependence Questtonnatre ts to be scored 
using the following technique. 
Questions 1 and 2 are to determine the subject's brand and type of cigarette. The nicotine content (tn milligrams per cigarette) ts obtained from the most recent listing of the Federal Trade Commtsston Report. Refer to the following pages for the Nicotine Content listing. The scoring of nicotine content ts as follows: · 
Low(< 0.6 mg ntcotlne/ctgarette) • O 
Moderate (0.6 · I.I mg nicotine/cigarette)• I 
High (> I.I mg nicotine/cigarette)• 2 
The scoring of other questions Is as follows: 
Question 3: within 1/2 hour• I 
over I/2 hour • 0 
Question 4: Ho • O 
Yes• I 
Question 5: the first cigarette tn the morning• I 
other• 0 
Question 6: Ho • 0 
Yes• 
Question 7: Ho • 0 
Yes• I 
Question 8: Never• 0 
Sometimes• 
Always• 2 
Question 9: Less than lS • 0 I6. 25. I 
More than 26 • 2 
Enter the score for each question tn the "Completed by the Investigator Only" 
section on the right side of the questionnaire. Total the score of each ques· 
tlon to get the total Fagerstrom Tobacco Dependence score. 
A total score of Q..=~ (Inclusive) Indicates low nicotine dependence. 
A total score or~ (Inclusive) Indicates high nicotine dependence. 
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Nicotine Content of Two Hundred Eleven Varieties of Domestic Cigarettes 
(Adapted from the Federal Trade COlll!llsslon Report) 
BRAND TESTED TYPE CODE NICOTINE CONTENT 
ALPINE F: SP: H 0.95 BARCLAY IOO F 0.40 BELAIR F: SP: H 0.74 BELAIR IOO F: SP: H 0.6I BENSON & HEDGES R: F: HP 0.07 BENSON & HEDGES F : HP I. IO BENSON & HEDGES JOO F : HP I.OZ BENSON & HEDGES JOO F: HP: H I. 01 BENSON & HEDGES IOO F : SP 1.03 BENSON l HEDGES 100 F: SP: H J.04 BENSON & HEDGES LIGHTS IOO F : SP 0.73 BENSON & HEDGES LIGHTS 100 F : SP: H 0. 70 BENSON & HEDGES ULTRA LIGHTS F : HP 0.40 BENSON & HEDGES ULTRA LIGHTS F HP: H 0.42 
BRIGHT F .SP : H 0.52 BRIGHT 100 F SP: H 0.52 BULL DURHAM F : SP 1.83 CAMBRIDGE F: HP • CAMBRIDGE F SP 0.08 CAMBRIDGE IOO F SP 0.44 CAMEL R.: NF SP 1.40 CAMEL F HP 1.08. CAMEL F SP 1.07 CAMEL LIGHTS F HP 0.69 CAMEL LIGHTS F SP 0.66 CAMEL LIGHTS IOO F SP 0.83 CAPRI LIGHTS F. 0.80 CARLTON F HP * CARLTON F : SP 0.1 I CARLTON F SP: H 0.07 CARLTON JOO F : HP 0.05 CARLTON IOO F HP: H * CARLTON JOO F : SP 0.40 CARLTON 100 F SP: H 0.41 CARLTON J20 F : SP 0.59 CARLTON IZO F SP : H 0.62 CENTURY F SP 0.94 CENTURY LIGHTS F SP 0.69 CHES TE RF I ELD R : HF SP I. 22 CHESTERFIELD NF SP I. 52 DO RADON F SP 0.90 DORAL II F : SP 0.38 DORAL II F : SP: H 0.38 
F·f11ter, NF•non·fllter, H•menthol, R•regular, HP•hard pack, SP·soft pack *Below the sensitivity of the method (0.05 mg nicotine). 
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Nicotine Content or Two Hundred Eleven Varieties or Domestic Cigarettes 
(Adapted from the Federal Trade Conrnlsslon Report) 
ENGLISH OVALS ENGLISH OVALS EVE LIGHTS 100 
EVE UGHTS 100 EVE LIGHTS 100 
EVE LIGHTS 120 GALAXY GENERIC ULTRA LIGHTS HALF & HALF HERBERT TAREYTON ICEBERG JOO 
KENT KENT KENT 100 
KENT 100 KENT GOLOEN LIGHTS KENT GOLDEN LIGHTS KENT GOLDEN LIGHTS 100 KENT GOLDEN LIGHTS JOO KENT II I 
KENT Ill JOO KOOL KOOL KOOL KOOL LIGHTS KOOL LIGHTS 100 KOOL f'llLDS KOOL MILDS 100 KOOL SUPER LONGS 100 KOOL ULTRA ' KOOL ULTRA JOO 
L & H 
L & H l & H 100 L & H LIGHTS l & H LIGHTS 100 LARK LARK 100 LARK LIGHTS LARK lJ GHTS 100 LUCKY STRIKE LUCKY STRIKE LUCKY STRIKE LUCKY STRIKE JOO 
R : NF : HP HF : HP F: HP F: HP: H F: HP 
F :: HP : H F: SP 
F: SP NF: SP 
.F SP : H F : HP F ·SP F ; SP 
F SP : H F : SP 
F SP : H F: SP F : SP : H F: SP F: SP 
R: NF : SP : H 
F : HP: H F : SP: H 
F : SP: H F : SP : H F : SP: H F : SP : H 
f : SP : H F : SP : H F : SP : H F: HP F: SP 



































F•fllter, NF•non·fllter, H•menthol, R•regular, HP•hard pack, SP•soft pack •Below the sensttlvtty of the method (0.05 mg nicotine). 
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Nicotine Content of Two Hundred Eleven Varieties of Domestic Cigarettes 
(Adapted from the Federal Trade Conmlsslon Report) 
MARLBORO F : HP 0.97 MARLBORO F : SP 1.00 MARLBORO F SP : H 0.96 MARLBORO 100 F HP 1.05 MARLBORO 100 F SP I.OS MARLBORO LIGHTS F HP 0.69 MARLBORO LIGHTS F SP 0.69 MARLBORO LIGHTS 100 F SP 0.71 MAX 120 F : SP 1. 40 MAX 120 F SP : H 1.44 MERIT F: SP 0.52 MERIT F SP : H 0.54 MERIT 100 F : SP 0.71 MERIT 100 F SP : M 0.67 MERIT ULTRA LIGHTS F : SP 0.38 MERIT ULTRA LIGHTS F SP: H 0.37 MERIT ULTRA LIGHTS 100 F: SP 0.43 MERIT ULTRA LIGHTS 100 F SP : H 0.35 MONTCLAIR F SP : H 0.98 HORE 120 F : SP 1.19 HORE 120 F SP : H 1. 21 HORE LIGHTS 100 F : HP 0.65 HORE LIGHTS 100 F HP : H 0.61 MULTI FILTER f : SP o. 77 HULTIFILTER F SP : H 0.76 NEWPORT f HP : H 1.14 NEWPORT F SP: H 1. Zl NEWPORT 100 F SP: H 1.46 NEWPORT LIGHTS f HP : H o. 72 NEWPORT LIGHTS f SP : H 0.70 NEWPORT LIGHTS 100 F SP : H 0.83 NEWPORT RED F : HP 0.94 NEWPORT RED F : SP 1.04 NOW F : HP • NOW F : SP 0. I I NOW F SP : H 0.09 NOW 100 f : HP 0.07 NOW 100 f : SP 0.27 NOW 100 f SP : H O.Z4 OLD GOLD f IL TER F SP I. ZS OLD GOLD FILTER 100 F : SP I.SZ OLD GOLD LIGHTS F: SP 0.82 OLD GOLD STRAIGHT NF : SP 1.62 PALL HALL NF: SP 1. 34 PALL HALL f: SP 1.11 
F•fllter, NF•non·fllter, M•menlhol, R•regular, HP·hard ~ack, SP•soft pack •Below the sensitivity of the method (0.05 mg nlcotlne. 
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Nicotine Content of Two Hundred Eleven Varfetles of Domestic Cigarettes 
(Adapted from the Federal Trade Corrmlsston Report) 
PALL MALL 100 PALL MALL EXlRA LIGHT PALL MALL LIGHT 100 PALL HALL LIGHT 100 PARLIAMENT LIGHTS PARLIAMENT LIGHTS PARLIAMENT LIGHTS 100 PHILIP MORRIS PHILIP MORRIS COMMANDER PHILIP MORRIS INTERNATIONAL 100 PHILIP MORRIS INTERNATIONAL 100 
PICAYUNE PLAYERS PLAYERS PLAYERS PLAYERS 100 PLAYERS 100 RALEIGH RALEIGH RALEIGH JOO RALEIGH LIGHTS RALEIGH LIGHTS 100 RICHLAND RlGHLANO RITZ 100 SALEH SALEH 100 SALEH LIGHTS SALEH LIGHTS 100 SALEH SLIM LIGHTS 100 SALEH ULTRA SALEH ULTRA 100 SARATOGA 120 SARATOGA 120 SATIN 100 SATlH 100 SILVA THINS 100 SILVA THIHS 100 SPRING 100 ST. MORITZ 100 ST. MORITZ 100 TALL l ZO TALL 120 
F: SP F: SP F: SP 
F SP : 11 F: HP F: SP F: SP R: HF : SP NF: SP F : HP F: HP: H R: NF: SP R: NF: HP F: HP F: HP: H F: HP F: HP: H NF: SP F: SP F: SP F: SP F: SP F: SP F: SP: H 
F : H F: SP: H 
F : SP : H 
F : SP : H F : SP : H 
F : HP : H 
F : SP : H F: SP: H F: HP F: HP: H F: SP F : SP : H 
F : SP 
f : SP : H 
f : SP : H F: SP 







































F·fllter, NF•non-fllter, M·menthol, R•regular, HP•hard pack, SP·soft pack •Below the sensitivity of the method (O.OS mg nicotine). 
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Nicotine Content of Two Hundred Eleven Varieties of Domestic Cigarettes 
(Adapted from the Federal Trade Commission Report) 
TAREYTON F SP 0.86 TAREYTON JOO F SP 0.93 TAR EYTON LIGHTS F SP 0.36 TAREYTON LONG LIGHTS 100 F SP 0.6Z TRIUMPH F: SP 0.30 TRIUMPH F SP : H 0.30 TRIUMPH 100 F: SP 0.41 TRIUMPH 100 F SP: H 0.39 TRUE F : SP 0.41 TRUE F SP : H 0.4Z TRUE 100 F : SP 0.6Z TRUE 100 F SP : H o.sa VANTAGE F : SP 0.71 VANTAGE F SP: M 0.67 VANTAGE JOO F: SP 0.71 VANTAGE JOO F: SP: HO 0. 72 VANTAGE ULTRA LIGHTS F : SP 0.43 VANTAGE ULTRA LIGHTS F : SP: H 0.40 VANTAGE ULTRA LIGHTS JOO F: SP 0.45 VANTAGE ULTRA LIGHTS JOO F : SP : H 0.44 VICEROY F: SP 0.94 VICEROY RICH LIGHTS F: SP 0.74 VICEROY RICH LIGHTS JOO F : SP 0.78 VICEROY SUPER LONG 100 F: SP 0.94 VIRGINIA SLIMS JOO F : SP 0.93 VIRGINIA SLIMS 100 F SP: H 0.94 VIRGINIA SLIMS LIGHTS JOO F : HP 0.57 VIRGINIA SLIMS LIGHTS JOO F HP : M 0.56 WINSTON F : HP 1.07 WINSTON F SP 1.06 WINSTON 100 F Sp 1.20 WINSTON INTERNATIONAL JOO F HP 1.10 WINSTON LIGHTS F SP 0.65 WINSTON LIGHTS JOO F SP 0.83 WINSTON ULTRA LIGHTS F : SP 0.4Z WINSTON ULTRA LIGHTS JOO F: SP 0.45 




Initial8 Study ea .. Humber _ 
Belov is a list of 15 aituationa in which people frequently amoke. 
Pleaee read each one carefully. Then circle the number underneath 
which best describes 11fE PROBABILITY THAT YOU lo'ILL BE ABLE TO RESIST 
11fE URGE TO SHOJ:E IM THAT SITUATION IN THE FUTURE IF TIIE SITUATION 
ARISES. If you are absolutely certain that you will not smoke in that 
situation, circle 100%. If you hava .!12. confidence in 7our ability to 
resist a cigarette in that situation, circle 0%. Please aelect only 
the percentagea and do not mark between the numbers. More likely, 
your confidence will vary. For example, if you are pretty aure that 
you vill be able to resist the urge to smoke if and vhen you vent to 
relax, but not absolutely certain, you might circle 80%. If you are 
pretty aura you vould .!!.,2S be able to~ a cigarette if that 
aituation ariaes, but not absolutely aura you couldn't, you might 
circle 20%. 
1. When you feel anxioua. 
0% - 10% - 20% - 30% - 40% - SO% - 60% - 70% - 80% - 90% - 100% 
2. When you vent to eit back and enjoy a cigarette. 
0% - 10% - 20% - 30% - 40% - ~% - 60% - 70% - 80% - 90% - 100% 
3. Whan you have finished a •eal or anack. 
0% - 10% - 20% - 30% - 40% - SO% - 60% - 70% - 80% - 90% - 100% 
4. When you are nervous. 
0% - 10% - 20% - 30% - 40% - SO% - 60% - 70% - 80% - 90% - 100% 
S. When you vent to feel more attractive. 
0% - 10% - 20% - 30% - 40% - ~% - 60% - 70% - 80% - 90% - 100% 
6. When you vent to relax. 
0% - 10% - 20% - 30% - 40% - SO% - 60% - 70% - 80% - 90% - 100% 
101 
7. When you feel smoking is part of your ealf-imaga. 
0% - ·10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100% 
8. When you feel tense. 
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100% 
9. When you are drinking an alcoholic be•eraga. 
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100% 
10. \ihen JOU aee others smoking. 
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100% 
11. \ihen someone offers JOU a cigarette. 
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100% 
12. \ihen JOU vent to avoid eating sweets. 
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100% 
13. \ihen you want to feel more mature and sophisticated. 
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100% 
14. \ihen JOU vant to keep alim. 
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100% 
15. What ia tha probability that you will be ebla to re1iet the urge 
to smoke altogether in the future, resardlaaa of the eituation? 




Means and Standard peviations of Self-efficacy and Tobacco 






M SP M SD 
Self-efficacy 
Tobacco Dependency 
55.467 14.438 46.967 17.775 




Means and Standard Deviations of Withdrawal Symptoms by 
Group. 
Group 
Normal Smokers COPD 
Cn=30) (n=30) 
M SP M SD 
Nicotine craving 1. 611 1. 335 2.400 1. 298 
Irritability 1.111 0.900 1.800 1.320 
Frustration 0.944 0.873 1. 867 1.302 
Anger 0.444 0.616 1. 533 1. 457 
Anxiety 0.889 0.832 2.067 1.163 
Difficulty concentrating 0.611 0.778 1. 667 1.447 
E~stl~ssness l1QOQ Q1270 ~1:2~3 Q.99Q 
APPENDIX K 
Q University of Nebraska Medical Center 
O.p1r1m1nl ol lnl1tn1I Medicine 
l'vl,,_oty Ind C~Uc11 Cue .. _ ... ...,, ..... 
4/4/90 
!rnest Prentlce, Ph.D. 
txecutlve Secretary 
In1tltutlonal Review Board 
5017 Conkling Hall 
UNHC 
R!1 IRB 1262-90 
Dear Dr. Prentlce, 
Thl1 letter l• to lnfor• you that my re1earch 
of Smoking Ce11atlon Hethod1 in Normal S•oker1 and 
Ob1tructlve Pul~onery Di1ea1e" ha• been co•pletad. 
entered the atudy. There vere no co•pllcatloa1. 
Slnceuly, 
/>1CL'-':r G. ,~~l.LLL.-., 'Pt4-·C.. 
Hary B. Mueller, PA-C 
Prlnclpal Inve1tlgator 
Unl•111llr of N1b•11,1-Llncofn Unl•111lly ol Nebr uh II Om1h1 
104 
800 South •2nd Slttel Om1ha, NE 63198-2•85 
(402) 559·4087 
entltled "A Co•perlaon 
Smoker• vlth Chronlc 
A total of 60 1•oker1 
Unln•1llr ol N11><uh M1dtc11 C.nll• 
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